,Feature_Name,novel,novel_cot,plausible,plausible_cot,Interesting?,Confidence,explanation,corr,p_val,feature_importance,MutualInfoTarget,F.Split-Lift (y==1),F.Split-Feature Split,not_boring,boring_cot,Target,Real,Util_Explanation,Utility,Utility_Score,Query,cui,cui_def,KG_Hits,sim_score,feature_level_sum_kg_hits,feature_level_avg_kg_hits,raw_name,sim_score_target_feat,sim_score_target_cui,shortest_path_length,simple_path_length,norm_path_length,Query Count,Target Count,Co-occurrence Count,Cooccurrence P-Value,MI,min_feat_kgHit,feature_level_sum_cooc_hits,correlation
28,missing_Essential hypertension,1,"The association between essential hypertension and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the literature. While some studies have explored various risk factors for gallbladder disease, essential hypertension has not been prominently featured as a significant risk factor. The negative correlation suggests that higher blood pressure may not be a contributing factor to these gallbladder conditions, which could be considered novel or surprising given the common focus on obesity and metabolic syndrome as risk factors. Therefore, this finding could provide new insights into the understanding of gallbladder disease risk factors, indicating that essential hypertension may not play a role as previously thought. Thus, it is reasonable to conclude that this association is novel and provides new insights into the relationship between hypertension and gallbladder diseases.",0,"Essential hypertension is primarily a cardiovascular condition characterized by elevated blood pressure, while cholelithiasis (gallstones) and related gallbladder diseases are primarily gastrointestinal conditions. The negative correlation of -0.026 suggests a very weak inverse relationship between essential hypertension and gallbladder diseases, indicating that as one increases, the other tends to decrease slightly, but this is not significant. There is no established mechanism linking hypertension directly to gallstone formation or gallbladder disease. While obesity and metabolic syndrome can influence both conditions, the direct association is weak and not well-supported by existing literature. Therefore, it does not make sense to assert a plausible explanation for a relationship between essential hypertension and gallbladder diseases based on known mechanisms or theories.",TRUE,3,"The feature 'Essential hypertension' has a negative correlation with gallbladder diseases, which is not well-documented in existing literature. This suggests a novel insight, as hypertension is often associated with metabolic syndrome, which could be expected to have a positive correlation with gallbladder diseases. The novelty lies in challenging the assumption that hypertension and gallbladder diseases share common risk factors. However, the plausibility of this association is weak, as there are no known biological mechanisms linking hypertension directly to a reduced risk of gallbladder diseases. The negative correlation is also very weak (-0.026), indicating that the relationship may not be clinically significant. While the finding is novel, its practical utility is limited due to the lack of a plausible mechanism and the weak correlation. Therefore, while the feature is somewhat interesting from a research perspective due to its novelty, it does not provide strong or actionable insights.",-0.026,0,0.005,0.017,1.14,missing_Essential hypertension < -0.57,TRUE,"The relationship between 'Essential hypertension' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not explicitly mentioned in the provided documents. However, the documents do mention that individuals with gallstones have a higher risk of hypertension, which suggests a potential correlation between the two. Furthermore, the documents also mention that obesity, which is a risk factor for essential hypertension, is also a risk factor for gallstone formation. Therefore, while the direct relationship between 'Essential hypertension' and the target disease is not explicitly stated, it can be inferred that there may be an indirect relationship through shared risk factors such as obesity.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"The negative correlation is small and not well established as a risk factor for gallbladder disease, offering little practical value in clinical decision-making or screening.",FALSE,1,,,,,,,,,,,,,,,,,,,,,negative
17,Home area population density - urban or rural_England/Wales - Village - less sparse,1,"The association between home area population density (urban or rural) and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the literature. While there are studies that discuss the prevalence of gallbladder diseases in relation to various socio-economic and environmental factors, the specific correlation with population density, particularly in rural versus urban settings, is less explored. The negative correlation suggests that as population density increases, the incidence of these gallbladder diseases decreases, which may contradict some established beliefs that urban living leads to higher rates of certain health issues due to lifestyle factors. Therefore, this feature does provide new insights into the relationship between population density and gallbladder diseases, indicating that it is a novel finding in the context of existing research.",1,"To determine if the feature 'Home area population density - urban or rural England/Wales - Village - less sparse' can be associated with 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the known mechanisms of gallbladder diseases and how they relate to population density and rural versus urban living. Gallbladder diseases, particularly cholelithiasis (gallstones), are often influenced by dietary factors, obesity, and lifestyle choices. Urban areas typically have higher access to fast food and processed foods, which can contribute to obesity and gallstone formation. Conversely, rural areas may have diets that are less processed and potentially healthier, which could lead to lower rates of gallbladder disease. The negative correlation of -0.013 suggests that as population density increases (moving from rural to urban), the incidence of gallbladder disease may decrease, which aligns with the idea that urban living may lead to dietary habits that increase the risk of gallbladder disease. Therefore, it makes sense that there could be a plausible explanation for this relationship based on dietary and lifestyle factors associated with urban versus rural living. Thus, the answer is A.",TRUE,3,"1. **Novelty:** The feature 'Home area population density - urban or rural England/Wales - Village - less sparse' is somewhat novel in the context of gallbladder diseases. The existing literature does not extensively cover the correlation between population density and gallbladder diseases, making this a relatively new area of exploration. The negative correlation, where higher population density is associated with lower incidence of these diseases, contradicts some common assumptions about urban living and health risks, adding to its novelty.

2. **Plausibility:** The plausibility of this feature is moderate. While urban areas are often associated with unhealthy diets and lifestyles that could increase the risk of gallbladder diseases, the negative correlation suggests the opposite. This could be explained by potential differences in healthcare access, lifestyle variations, or unmeasured confounders in rural versus urban settings. However, this explanation is not strongly supported by established mechanisms, making it less plausible without further investigation.

3. **Usefulness:** The practical utility of this feature is limited unless further research can establish a causal mechanism. It could potentially inform public health strategies if the association is proven to be causal and significant, but currently, its application is speculative.

Overall, the feature is interesting due to its novelty and the unexpected nature of the correlation, though its plausibility and immediate utility are limited.",-0.013,0,0.004,0,1.01,Home area population density - urban or rural_England/Wales - Village - less sparse < 0.50,TRUE,"The relationship between home area population density and the incidence of gallbladder disease is not directly related to the specific feature 'Home area population density - urban or rural England Wales - Village - less sparse'. The provided documents do not explicitly mention this specific feature as a risk factor for gallbladder disease. However, the documents do mention that socioeconomic and cultural factors, such as accessibility to healthcare facilities and quality of care, can affect the management and outcomes of gallbladder disease. Additionally, the incidence of gallbladder disease is influenced by factors such as age, sex, obesity, and genetic predisposition, but the specific feature of population density in rural areas is not directly linked to the development of gallbladder disease. Therefore, the association between this feature and the target disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"While intriguing from an epidemiological perspective, the correlation is weak and overshadowed by individual metabolic/lifestyle factors, limiting direct clinical utility.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
35,Skin colour_Very fair,1,"The association between skin color, particularly 'very fair' skin, and gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis is not well-documented in the current biomedical literature. While certain demographic factors, including gender and obesity, are known to influence the risk of gallbladder disease, the specific impact of skin color has not been extensively studied or established as a risk factor. Therefore, the suggestion that 'very fair' skin color has a positive correlation with these diseases could be considered novel, as it does not align with the established understanding of risk factors for gallbladder disease. This could provide new insights into the epidemiology of gallbladder diseases, suggesting that further research is warranted to explore this potential association. Thus, the conclusion is that this feature is novel.",0,"The relationship between skin color and gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis is not well-established in the medical literature. While certain demographic factors, including ethnicity and gender, can influence the prevalence of gallbladder diseases, skin color itself does not have a direct biological mechanism linking it to these conditions. The positive linear correlation of 0.008 is very weak and suggests that there is no significant relationship. Therefore, without a clear biological or epidemiological basis for this association, it does not make sense to claim that 'Skin colour Very fair' is plausibly associated with gallbladder diseases. Thus, the answer is B.",TRUE,3,"The feature 'Skin colour Very fair' is considered novel because there is no well-documented literature linking skin color directly to gallbladder diseases such as cholelithiasis or cholecystitis. Most known risk factors for these diseases are related to demographic factors like gender, age, and obesity, rather than skin color. This makes the feature novel as it suggests a potential new area of investigation. However, the plausibility of this feature being a true risk factor is low. There is no known biological mechanism that would directly connect skin color to gallbladder disease risk. The weak correlation and lack of a clear biological pathway reduce the plausibility of this association. Therefore, while the feature is novel, its practical usefulness is limited unless further research can establish a plausible mechanism or stronger association. Given these considerations, the feature is somewhat interesting due to its novelty, but its low plausibility limits its overall interest to researchers.",0.008,0,0.001,0.001,1.08,Skin colour_Very fair >= 0.50,TRUE,"The feature 'Skin colour_Very fair' is not directly related to the formation of gallstones or gallbladder disease. The risk factors for gallbladder disease include female gender, obesity, rapid weight loss, pregnancy, advanced age, and Hispanic or Pima Indian ethnicity, but skin color is not a known risk factor. The formation of gallstones is primarily influenced by factors such as cholesterol supersaturation, excess bilirubin, and gallbladder hypomotility, rather than skin color. Therefore, the association between 'Skin colour Very fair' and the target disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"No known biological mechanism links very fair skin color to gallbladder disease; the correlation is negligible, with minimal potential for actionable use.",FALSE,1,,,,,,,,,,,,,,,,,,,,,positive
45,Actinic keratosis,,,,,,,"Actinic keratosis is interesting because it has a positive correlation with gallstones, which suggests a potential link between skin cancer precursors and gallbladder disease. This association is plausible given that both conditions are related to chronic sun exposure and UV radiation, which can cause DNA damage and mutations leading to skin cancer and potentially gallbladder disease. This connection could have implications for prevention and early detection strategies for both conditions.",0.003,0.948,0,0,,,,,(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),0,No recognized connection or mechanism with gallbladder disease; extremely weak correlation provides no meaningful clinical application.,FALSE,1,Actinic keratosis,C0022602,"Actinic keratosis. White or pink lesions on the arms, hands, face, or scalp that arise from sun-induced DNA DAMAGE to KERATINOCYTES in exposed areas. They are considered precursor lesions to superficial SQUAMOUS CELL CARCINOMA.",0,0.893,0,0,Actinic keratosis,0.12,0.12,2,0,0,4905,100459,0,0,0,0,0,positive
3,Frequency of tiredness / lethargy in last 2 weeks_Nearly every day,1,"The feature 'Frequency of tiredness / lethargy in last 2 weeks Nearly every day' suggests a significant level of fatigue that could be associated with various medical conditions, including those affecting the gallbladder and biliary system. While lethargy can be a symptom of many diseases, including infections and inflammatory conditions, the specific association with gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis is not prominently documented in the literature. The documents primarily focus on the physical symptoms like abdominal pain, nausea, and vomiting as more direct indicators of gallbladder disease. Therefore, while lethargy may occur in patients with these conditions, it is not a well-established or commonly recognized symptom directly linked to gallbladder diseases. This suggests that the association may be novel or not well-documented, providing new insights into the symptomatology of gallbladder diseases. Thus, the answer is A.",1,"To determine if there is a plausible explanation for the association between 'Frequency of tiredness / lethargy in last 2 weeks Nearly every day' and conditions like Cholelithiasis, Gallstone, Gallbladder disease, Cholecystitis, or Cholangitis, we need to consider the underlying mechanisms of these diseases. Cholelithiasis and related gallbladder diseases can lead to symptoms such as abdominal pain, nausea, and vomiting, which may contribute to a general feeling of malaise or lethargy. Additionally, complications from these conditions, such as inflammation or infection (e.g., cholecystitis or cholangitis), can cause systemic symptoms including fatigue and lethargy due to the body's response to inflammation. Therefore, it is reasonable to hypothesize that individuals suffering from these gallbladder-related conditions may experience increased tiredness or lethargy as a result of their illness. The positive linear correlation of 0.034, while weak, suggests a slight association, which could be explained by the systemic effects of gallbladder disease on overall health and energy levels. Thus, there is a plausible explanation for this relationship.",TRUE,4,"1. **Novelty:** The feature 'Frequency of tiredness / lethargy in last 2 weeks Nearly every day' is not commonly associated with gallbladder diseases in existing literature. Most documented symptoms of gallbladder diseases include abdominal pain, nausea, and vomiting, rather than systemic symptoms like tiredness or lethargy. This suggests that the feature could be novel or underexplored in the context of gallbladder diseases, providing potentially new insights into the symptomatology of these conditions.

2. **Plausibility:** There is a plausible biological explanation for the association. Gallbladder diseases can lead to systemic symptoms due to inflammation or infection, which might cause fatigue or lethargy. Although the correlation is weak (0.034), it is still positive, indicating some level of association. The body's response to inflammation or infection could logically lead to increased tiredness, making the association plausible.

3. **Usefulness/Utility:** While the feature could be novel and plausible, its practical utility in clinical settings might be limited due to the weak correlation. However, it could still be useful for further research into the broader symptomatology of gallbladder diseases and might inform future studies or models that aim to predict these conditions.

Overall, the feature is interesting due to its novelty and plausible connection to gallbladder diseases, despite the weak correlation, which suggests further exploration could be warranted.",0.034,0,0.006,0.002,1.35,Frequency of tiredness / lethargy in last 2 weeks_Nearly every day >= 0.50,TRUE,"The feature 'Frequency of tiredness / lethargy in last 2 weeks_Nearly every day' is related to the target disease 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis'. The relationship between the two is not explicitly mentioned in the provided documents. However, it can be inferred that the feature might be related to the disease as it is a common symptom of various gastrointestinal diseases, including gallbladder disease. The feature might be used as a potential indicator for further investigation or diagnosis of the target disease. However, the exact relationship and its strength are not well established in the provided documents.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Fatigue is highly nonspecific and can arise from many conditions; it offers limited direct usefulness in predicting gallbladder disease risk.,FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
1,Apolipoprotein A Blood biochemistry,1,"The relationship between Apolipoprotein A and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not extensively documented in the provided literature. While Apolipoprotein B has been studied in relation to gallstone disease, Apolipoprotein A's specific role and its negative correlation with these diseases suggest a potential area of exploration that is not well-established. This indicates that the association may be novel or at least not widely recognized in current medical literature, thus providing new insights into the understanding of gallbladder diseases. Therefore, the feature does not contradict established understanding but rather opens up new avenues for research.",1,"Apolipoprotein A (ApoA) is primarily associated with high-density lipoprotein (HDL) and plays a crucial role in lipid metabolism and cholesterol transport. In the context of gallbladder diseases such as cholelithiasis, the formation of gallstones is often linked to cholesterol metabolism. A negative correlation of -0.031 suggests that as levels of ApoA increase, the incidence of gallbladder disease may decrease, which aligns with the role of ApoA in promoting cholesterol efflux and potentially reducing cholesterol saturation in bile. This could imply that higher ApoA levels might be protective against gallstone formation. Therefore, it does make sense to associate ApoA blood biochemistry with gallbladder diseases, as it relates to cholesterol metabolism, which is a key factor in gallstone pathogenesis. Thus, there is a plausible explanation for this relationship.",TRUE,4,"The feature 'Apolipoprotein A Blood biochemistry' in relation to gallbladder diseases is interesting primarily due to its novelty. While Apolipoprotein B has been more commonly associated with gallstone disease, the specific role of Apolipoprotein A is not well-documented, suggesting a new avenue for research. This indicates a novel aspect as it is not widely recognized in existing literature, providing new insights into gallbladder disease mechanisms. From a plausibility standpoint, Apolipoprotein A is involved in lipid metabolism and cholesterol transport, which are relevant to gallstone formation. The negative correlation suggests that higher levels of Apolipoprotein A could be protective against gallstone formation, aligning with its role in promoting cholesterol efflux. This makes logical sense given the cholesterol-related pathogenesis of gallstones. Therefore, the feature is both novel and plausible, making it interesting to researchers exploring new biomarkers or mechanisms in gallbladder diseases.",-0.031,0,0.014,0,1.39,#NAME?,TRUE,"Apolipoprotein A is a protein that plays a crucial role in lipid metabolism and transport. It is a component of high-density lipoprotein (HDL), which is often referred to as 'good cholesterol.' Apolipoprotein A has been shown to have a protective effect against cardiovascular diseases, including atherosclerosis and coronary artery disease. However, its relationship with gallbladder disease, such as cholelithiasis, gallstones, and cholecystitis, is not as well established. While some studies suggest that apolipoprotein A may have a role in the pathogenesis of gallstones, particularly in relation to its interaction with other proteins and lipids in the bile, the evidence is not as strong as its association with cardiovascular diseases. Therefore, the association between apolipoprotein A blood biochemistry and gallbladder disease is not as well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Ties to cholesterol and lipid metabolism may be relevant for gallstone pathogenesis; as a measurable biomarker, it has moderate potential utility in risk assessment.",TRUE,3,,,,,,,,,,,,,,,,,,,,,negative
24,(BC) breast cancer genetic risk,1,"The relationship between breast cancer genetic risk (specifically related to BRCA mutations) and gallbladder diseases such as cholelithiasis or cholecystitis is not well-documented in the literature. While both conditions have established risk factors, the direct association between breast cancer genetic risk and gallbladder disease is not commonly discussed or recognized in current medical literature. The existing documents primarily focus on the individual risk factors for each condition without establishing a clear link between them. Therefore, the suggestion that there is a positive correlation between breast cancer genetic risk and gallbladder disease is novel and not widely recognized, indicating that it may provide new insights into the interplay between these two health issues. Thus, the answer is A.",0,"To determine if there is a plausible explanation for the association between 'BC breast cancer genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the known risk factors and mechanisms for both conditions. Breast cancer (BC) has several genetic risk factors, particularly mutations in genes like BRCA1 and BRCA2, which significantly increase the risk of developing breast cancer. On the other hand, gallbladder diseases, including cholelithiasis and cholecystitis, are often associated with chronic inflammation and other risk factors such as obesity and certain infections. While there is a known association between obesity and both breast cancer and gallbladder disease, the linear correlation of 0.004 suggests a very weak relationship. The documents do not provide a direct mechanism linking breast cancer genetic risk with gallbladder diseases. Therefore, while there may be some indirect associations through shared risk factors like obesity, there is no strong or direct plausible explanation for a significant relationship between the two. Thus, the answer is B.",TRUE,3,"The feature 'BC breast cancer genetic risk' being correlated with gallbladder diseases is indeed novel because there is limited existing literature that directly connects these two conditions. Typically, breast cancer genetic risks, such as BRCA mutations, are associated with breast and ovarian cancers, not gallbladder diseases. This lack of documentation makes the correlation novel. However, the plausibility of this association is weak. There is no well-established biological mechanism linking breast cancer genetic risks directly to gallbladder diseases. While both conditions might share some common risk factors like obesity, this does not establish a direct causal or plausible link. The correlation might be due to confounding factors not accounted for, or it might be a spurious correlation. Given the novelty but low plausibility, the feature is somewhat interesting from a research perspective as it could prompt further investigation into potential indirect links or shared pathways. However, due to the weak plausibility, it might not be immediately useful for clinical applications without further evidence.",0.004,0.039,0.008,0,1.87,#NAME?,TRUE,"The association between 'BC breast cancer genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not directly related. The provided documents do not mention any connection between breast cancer genetic risk and the development of gallstones or gallbladder disease. The risk factors mentioned in the documents include cholelithiasis, obesity, female gender, rapid weight loss, pregnancy, advanced age, and Hispanic or Pima Indian ethnicity. Therefore, the association is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Extremely weak correlation with no strong mechanism for gallbladder disease; not clinically informative for gallbladder risk.,FALSE,1,,,,,,,,,,,,,,,,,,,,,positive
26,Sodium in urine,1,"The association between sodium in urine and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the provided literature. While there are discussions about gallstones and their complications, the specific correlation with sodium levels in urine is not mentioned. Therefore, this suggests that the relationship may not be widely recognized or established in current medical understanding. Given that the question indicates a positive correlation with the target disease, it implies that this could be a new area of exploration. Thus, it can be concluded that this association is novel and may provide new insights into the understanding of gallbladder diseases.",0,"Cholelithiasis (gallstones) and related gallbladder diseases are primarily influenced by factors such as bile composition, gallbladder motility, and dietary habits. Sodium levels in urine can reflect dietary sodium intake and overall fluid balance, which may indirectly influence bile composition and gallstone formation. However, the linear correlation of 0.007 suggests a very weak relationship, indicating that while there may be some connection, it is not strong enough to establish a direct causal link. The mechanisms by which sodium in urine could affect gallstone disease are not well established in the literature, making it difficult to assert a clear and plausible explanation for this relationship. Therefore, while there may be some theoretical basis for a connection, the evidence does not strongly support it. Thus, the answer is B.",TRUE,3,"The feature 'Sodium in urine' is evaluated for its novelty and plausibility in relation to gallbladder diseases. In terms of novelty, the association between urinary sodium levels and gallbladder diseases is not well-documented in the literature, which suggests that it could be a novel area of research. This lack of documentation indicates that the feature might provide new insights into the pathophysiology of these diseases, making it potentially interesting from a research perspective. However, the plausibility of this association is questionable. Gallbladder diseases are primarily linked to factors like bile composition and gallbladder motility, and while dietary sodium intake could theoretically influence these factors indirectly, there is no strong biological mechanism currently known that directly links urinary sodium levels to gallbladder disease development. The weak correlation further suggests that any relationship is likely indirect or confounded by other factors. Therefore, while the feature is novel, its plausibility is low, which reduces its overall interest level for researchers. Given these considerations, the feature is somewhat interesting due to its novelty but not highly compelling due to the lack of a plausible mechanism.",0.007,0.001,0.006,0.002,1.34,3.10 <= Sodium in urine < 3.80,TRUE,"The relationship between 'Sodium in urine' and the target disease 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not explicitly mentioned in the provided documents. However, we can infer that the feature 'Sodium in urine' is not directly related to the formation or prediction of the target disease. The documents primarily focus on the etiology, pathophysiology, and risk factors of gallbladder diseases, but do not mention sodium in urine as a risk factor or predictive feature. Therefore, the association between 'Sodium in urine' and the target disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Might reflect dietary salt intake and fluid balance, but the very weak correlation offers little actionable insight for gallbladder disease risk.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
40,Cholesterol in Medium HDL,1,"The relationship between cholesterol levels, particularly in high-density lipoproteins (HDL), and gallbladder diseases such as cholelithiasis (gallstones) is a well-documented area in medical literature. HDL is often referred to as 'good cholesterol' and is associated with protective effects against cardiovascular diseases. However, the specific association of 'Cholesterol in Medium HDL' with gallbladder diseases is less commonly discussed. The documents indicate that low HDL levels are associated with increased risk for cardiovascular diseases, but they do not provide a direct correlation between medium HDL cholesterol levels and gallbladder diseases. Given that the feature has a negative correlation with the target diseases, it suggests that higher levels of medium HDL cholesterol may be protective against gallbladder diseases, which is not a widely recognized or established understanding. Therefore, this could be considered novel or at least provides new insights into the relationship between cholesterol levels and gallbladder health.",0,"To determine if the feature 'Cholesterol in Medium HDL' is associated with 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the role of HDL cholesterol in gallbladder health. HDL is often referred to as 'good cholesterol' because it helps transport cholesterol back to the liver for excretion. Higher levels of HDL cholesterol are generally associated with better cardiovascular health and lower risk of atherosclerosis. However, the relationship between HDL cholesterol and gallbladder diseases is complex. While low HDL levels are associated with increased risk of cardiovascular diseases, the correlation with gallbladder diseases is less clear. The negative correlation of -0.017 suggests that as 'Cholesterol in Medium HDL' increases, the incidence of gallbladder diseases does not significantly change, indicating that higher levels of this cholesterol type may not be protective against gallstone formation. Given that the mechanisms of gallstone formation involve cholesterol supersaturation in bile, the presence of cholesterol in HDL may not directly influence gallstone disease. Therefore, it is reasonable to conclude that there is no strong or plausible explanation for a direct association between 'Cholesterol in Medium HDL' and gallbladder diseases, especially given the negative correlation observed.",TRUE,3,"The feature 'Cholesterol in Medium HDL' is evaluated for its novelty and plausibility in relation to gallbladder diseases. Novelty is considered because the specific association of cholesterol levels within medium HDL particles with gallbladder diseases is not widely recognized or established in the literature. Most research focuses on total HDL levels rather than specific subfractions like medium HDL. This suggests that the feature could provide new insights into lipid metabolism and gallbladder disease risk, making it potentially novel. However, the plausibility of this association is questionable. HDL is known for its role in reverse cholesterol transport, which is beneficial for cardiovascular health, but its direct impact on gallbladder diseases is less clear. Gallstone formation is primarily related to cholesterol supersaturation in bile, and while HDL influences overall cholesterol homeostasis, its specific role in gallbladder disease is not well-defined. The negative correlation observed (-0.017) is weak, suggesting that higher levels of cholesterol in medium HDL may not significantly impact gallbladder disease risk. Therefore, while the feature is novel, its biological plausibility is not strong, and the weak correlation reduces its potential impact. Overall, the feature is somewhat interesting due to its novelty but lacks strong plausibility and utility without further research to elucidate the mechanisms involved.",-0.017,0,0.002,0,1.37,#NAME?,FALSE,"The relationship between 'Cholesterol in Medium HDL' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is well established in medical literature. Cholesterol stones are the most common type of gallstones, accounting for 75% of cases, and are associated with increased cholesterol levels in the bile. The formation of cholesterol stones is influenced by various factors, including high cholesterol levels, obesity, and a diet high in saturated fats and low in fiber. Therefore, the feature 'Cholesterol in Medium HDL' is a known risk factor for the development of cholelithiasis and related conditions.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Though HDL relates to cholesterol metabolism (a factor in gallstone formation), the correlation here is small, suggesting only mild practical utility.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
30,(AST) asthma genetic risk,1,"The question asks whether the association between asthma genetic risk and gallbladder diseases (including cholelithiasis, gallstones, cholecystitis, and cholangitis) is novel or well-documented. The documents provided do not indicate any established link between asthma genetic risk and gallbladder diseases. While there are discussions about gallbladder diseases and their risk factors, asthma is primarily discussed in the context of respiratory conditions and atopy. Therefore, the association appears to be novel and not well-documented in the current literature, suggesting that it may provide new insights into the relationship between these conditions. Thus, the answer is A.",0,"To determine if there is a plausible explanation for the association between asthma genetic risk and gallbladder diseases (cholelithiasis, gallstones, cholecystitis, cholangitis), we need to consider the underlying mechanisms of both conditions. Asthma is primarily an inflammatory disease influenced by genetic and environmental factors, while gallbladder diseases are often related to metabolic factors, obesity, and dietary influences. The linear correlation of 0.005 suggests a very weak relationship, indicating that while there may be some connection, it is not strong. The documents do not provide any direct evidence linking asthma genetic risk to gallbladder diseases. Therefore, without a clear biological mechanism or strong epidemiological evidence to support this association, it is reasonable to conclude that there is no plausible explanation for this relationship.",TRUE,3,"1. **Novelty:** The association between asthma genetic risk and gallbladder diseases is not well-documented in existing literature. Asthma is generally associated with respiratory conditions and atopic diseases, while gallbladder diseases are linked to metabolic factors. The lack of established connections between these two distinct areas suggests that this feature is novel.

2. **Plausibility:** There is no clear biological mechanism or pathway that directly links asthma genetic risk to gallbladder diseases. Asthma involves inflammatory pathways and immune responses, whereas gallbladder diseases are influenced by cholesterol metabolism and bile composition. Without a known mechanism or strong epidemiological evidence, the plausibility of this association is weak.

3. **Usefulness:** While the novelty of the association might spark interest for exploratory research, the lack of plausible biological explanation limits its immediate utility in clinical practice or policy-making. It may, however, encourage further investigation into potential indirect links or shared risk factors.

Overall, the feature is interesting primarily due to its novelty, but the low plausibility reduces its overall impact. It might be worth exploring further in research settings to uncover any indirect pathways or shared genetic factors.",0.005,0.002,0.004,0.002,1.17,#NAME?,TRUE,"The association between the feature '(AST) asthma genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not directly related. AST (aspartate aminotransferase) is a liver enzyme that can be elevated in cases of cholelithiasis, but it is not a genetic risk factor for asthma. The risk factors for cholelithiasis include obesity, metabolic syndrome, female gender, and genetic predisposition, but asthma is not directly related to the development of gallstones or gallbladder disease. Therefore, the association between '(AST) asthma genetic risk' and the target diseases is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"No clear biological rationale or robust correlation with gallbladder disease, yielding negligible clinical utility.",FALSE,1,,,,,,,,,,,,,,,,,,,,,positive
0,Major dietary changes in the last 5 years_No,1,"The association between 'dietary changes in the last 5 years' and conditions such as cholelithiasis, gallstones, gallbladder disease, cholecystitis, or cholangitis is not well-documented in the literature. While dietary factors are known to influence gallbladder health, the specific correlation of major dietary changes in the last 5 years with these conditions, particularly a negative correlation, is not commonly discussed. Most existing literature emphasizes the role of obesity, high cholesterol diets, and rapid weight loss as risk factors for gallstone formation. Therefore, a negative correlation suggesting that dietary changes could reduce the risk of these conditions is novel and could provide new insights into dietary management for gallbladder diseases. This contradicts the established understanding that poor dietary habits contribute to gallbladder disease. Thus, the feature is considered novel.",1,"To determine if the feature 'dietary changes in the last 5 years' is associated with 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the known mechanisms of gallstone formation and the impact of diet on gallbladder health. Dietary factors, particularly those that influence cholesterol levels and bile composition, play a significant role in the formation of gallstones. A diet high in cholesterol and low in fiber can increase the risk of gallstone disease. Conversely, dietary changes that promote weight loss and reduce cholesterol intake can potentially lower the risk of gallstones. The negative correlation of -0.034 suggests that as dietary changes increase, the incidence of gallbladder disease decreases, which aligns with the understanding that healthier dietary habits can reduce the risk of gallstones. Therefore, it makes sense that a lack of significant dietary changes could be associated with a higher risk of gallbladder disease. Thus, there is a plausible explanation for this relationship based on the known dietary influences on gallbladder health and gallstone formation.",TRUE,4,"The feature 'dietary changes in the last 5 years' is interesting due to its novelty. The literature does not extensively cover the specific impact of recent dietary changes on gallbladder diseases, making this association a relatively unexplored area. Typically, the focus has been on specific dietary components like cholesterol and fiber, rather than the act of changing one's diet. The negative correlation suggests that recent dietary changes might reduce the risk of gallbladder diseases, which is intriguing as it challenges the conventional focus on static dietary habits. From a plausibility standpoint, it is logical that healthier dietary changes could lead to a reduced risk of gallbladder diseases, as diet influences cholesterol levels and bile composition, both of which are critical in gallstone formation. However, the correlation is weak, and the feature lift is modest, indicating that while the association is plausible, it might not be strong enough to have immediate practical applications. Nevertheless, the novelty of the feature and its potential to inspire new research directions make it interesting to researchers.",-0.034,0,0.023,0.031,1.12,Major dietary changes in the last 5 years_No < 0.50,TRUE,"The association between 'dietary changes in the last 5 years' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not explicitly mentioned in the provided documents. However, it is mentioned that rapid weight loss or prolonged fasting can diminish gallbladder contractility and increase biliary secretion of cholesterol, which can lead to gallstone formation. Additionally, a low-fat diet, increased physical activity, and healthy weight are advised to reduce the risk of gallstone disease. Therefore, it can be inferred that significant dietary changes, such as rapid weight loss or a drastic change in diet, may have an impact on the risk of gallstone disease. However, the specific association between 'dietary changes in the last 5 years' and the target disease is not explicitly stated in the provided documents.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Diet is an important contributor to gallstone risk; tracking recent dietary stability/changes can moderately inform risk stratification.,TRUE,3,,,,,,,,,,,,,,,,,,,,,negative
4,(HT) hypertension genetic risk,1,"The relationship between hypertension (HT) and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not extensively documented in the literature. While hypertension is a well-known risk factor for various cardiovascular diseases, its direct association with gallbladder diseases is less clear. The documents provided do not explicitly link hypertension genetic risk with gallbladder diseases, suggesting that this connection may not be well-established or widely recognized. Therefore, the potential association could be considered novel or at least not well-documented in current knowledge, indicating that it may provide new insights into the understanding of gallbladder disease risk factors. Thus, the answer is A.",1,"To determine if there is a plausible explanation for the association between hypertension genetic risk and gallbladder diseases (including cholelithiasis, gallstones, cholecystitis, and cholangitis), we need to consider the underlying mechanisms of both conditions. Hypertension is often linked to metabolic syndrome, which includes obesity, insulin resistance, and dyslipidemia. These factors can contribute to gallstone formation due to altered bile composition and gallbladder motility. Additionally, chronic inflammation associated with hypertension may exacerbate gallbladder diseases. The positive linear correlation of 0.008 suggests a weak association, but it does not rule out the possibility of shared risk factors or mechanisms. Therefore, it is reasonable to conclude that there is a plausible explanation for the relationship between hypertension genetic risk and gallbladder diseases, as both conditions may share common metabolic pathways and risk factors.",TRUE,4,"1. **Novelty:** The association between hypertension genetic risk and gallbladder diseases is not well-documented in existing literature. While hypertension is a known risk factor for cardiovascular diseases, its connection to gallbladder diseases is not extensively explored. This suggests a novel area of research, as it could uncover new insights into the risk factors for gallbladder diseases that are not currently well-understood.

2. **Plausibility:** There is a plausible biological mechanism linking hypertension and gallbladder diseases through metabolic syndrome. Hypertension is often associated with metabolic syndrome, which includes obesity, insulin resistance, and dyslipidemia. These factors are known to contribute to gallstone formation due to changes in bile composition and gallbladder motility. Additionally, chronic inflammation, a common factor in hypertension, could exacerbate gallbladder diseases. Therefore, the association is plausible based on shared metabolic pathways.

3. **Usefulness:** Understanding the genetic risk of hypertension in relation to gallbladder diseases could have practical applications in identifying individuals at higher risk for these diseases. It could inform clinical interventions or guide further research into preventative strategies for gallbladder diseases.

Given the novelty and plausibility of the association, this feature is interesting to researchers as it opens new avenues for understanding the risk factors and mechanisms underlying gallbladder diseases.",0.008,0,0.004,0.001,1.5,(HT) hypertension genetic risk >= 3.20,TRUE,"The relationship between hypertension genetic risk and gallbladder disease is not directly mentioned in the provided documents. However, the documents do discuss the relationship between hypertension and cardiovascular disease, which is a known risk factor for gallbladder disease. Additionally, the documents mention that individuals with diabetes, which is also a risk factor for cardiovascular disease, have a higher risk of gallstones. Furthermore, the documents discuss the role of genetic factors in gallstone formation, but do not specifically mention hypertension genetic risk as a risk factor for gallbladder disease. Therefore, the association between hypertension genetic risk and gallbladder disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"A small positive correlation possibly reflecting shared metabolic pathways, but currently of limited direct utility for gallbladder risk.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
5,(CED) coeliac disease genetic risk,1,"The association between coeliac disease and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the literature. While coeliac disease is primarily known for its gastrointestinal manifestations and associations with other autoimmune diseases, the specific link to gallbladder diseases is less emphasized. However, some documents mention that Crohn's disease, which shares genetic susceptibility with coeliac disease, can lead to gallbladder issues due to its effects on the ileum. This suggests a potential indirect relationship rather than a direct one. Therefore, the association of coeliac disease genetic risk with gallbladder diseases could be considered novel or at least not well-established in current knowledge, as it does not contradict existing understanding but rather highlights an area that requires further exploration.",1,"Coeliac disease is an autoimmune condition that primarily affects the gastrointestinal tract, but it can also have systemic effects, including potential associations with other diseases. The documents indicate that coeliac disease is linked to various autoimmune diseases and conditions, including those affecting the biliary system. Document [12] mentions that Crohn's disease, which has genetic overlap with coeliac disease, can increase the risk of gallstones due to decreased bile acid resorption. Additionally, Document [20] discusses primary sclerosing cholangitis, which is associated with inflammatory bowel disease (IBD) and can lead to gallbladder disease. While the linear correlation of 0.004 is weak, it suggests a very minimal association. However, the underlying mechanisms connecting coeliac disease to gallbladder-related conditions may involve shared genetic predispositions or inflammatory processes that affect both the gut and biliary systems. Therefore, while the correlation is weak, there are plausible mechanisms that could explain a relationship between coeliac disease genetic risk and gallbladder diseases, particularly through the lens of shared autoimmune pathways and genetic factors. Thus, it makes sense to consider that there is a plausible explanation for this relationship.",TRUE,4,"The feature '(CED) coeliac disease genetic risk' is interesting to evaluate in the context of gallbladder diseases for several reasons. Firstly, the novelty of this association is moderate. While coeliac disease is known for its gastrointestinal and autoimmune implications, its specific link to gallbladder diseases is not well-documented, making this association relatively novel. The potential indirect relationship through shared genetic susceptibilities with conditions like Crohn's disease adds an intriguing layer that is not fully explored in the literature. Secondly, the plausibility of this association is supported by the autoimmune nature of coeliac disease, which could theoretically influence gallbladder health through systemic inflammatory processes or shared genetic pathways. Although the direct correlation is weak, the plausible biological mechanisms provide a foundation for further investigation. Lastly, the utility of this feature could be significant in advancing our understanding of autoimmune contributions to gallbladder diseases, potentially informing genetic screening or risk assessment strategies. Overall, the feature is moderately interesting due to its novelty and plausible biological underpinnings, warranting further research.",0.004,0.073,0.004,0,1.07,#NAME?,TRUE,"The relationship between coeliac disease genetic risk and gallbladder disease is not explicitly mentioned in the provided documents. However, coeliac disease is mentioned as one of the autoimmune conditions associated with gallbladder disease in Document [2]. This suggests that there may be a link between coeliac disease genetic risk and an increased risk of gallbladder disease, but it is not explicitly stated as a known risk factor. Therefore, the association is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Weak correlation; although there may be autoimmune or GI overlap, this is not strong enough to be clinically actionable for gallbladder disease risk.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
8,(HBA1C_DF) glycated haemoglobin genetic risk,1,"The association between 'HBA1C DF glycated haemoglobin genetic risk' and conditions such as cholelithiasis, gallstones, gallbladder disease, cholecystitis, or cholangitis is not well-documented in the current literature. While there is a known relationship between metabolic factors, including diabetes and gallbladder disease, the specific genetic risk factors related to glycated hemoglobin (HbA1c) and their direct correlation with gallbladder conditions have not been extensively explored or established. Therefore, this association could be considered novel as it may provide new insights into the genetic predisposition of gallbladder diseases in relation to metabolic health. This suggests that the feature could indeed provide new insights or contradict established understanding regarding the interplay between metabolic disorders and gallbladder diseases.",1,"The relationship between 'HBA1C DF glycated haemoglobin genetic risk' and gallbladder diseases such as cholelithiasis, gallstones, cholecystitis, and cholangitis can be explored through the lens of metabolic and genetic factors. Glycated hemoglobin (HbA1c) is a marker of long-term blood glucose levels and is associated with diabetes. Diabetes and obesity are known risk factors for gallstone formation and gallbladder disease due to altered bile composition and gallbladder motility. The positive linear correlation of 0.002 suggests a very weak association, but it indicates that as HbA1c levels increase, there may be a slight increase in the risk of gallbladder diseases. This could be due to the metabolic disturbances associated with higher HbA1c levels, which may lead to conditions favorable for gallstone formation. Therefore, there is a plausible mechanism linking glycated hemoglobin levels to gallbladder disease through metabolic pathways and risk factors associated with diabetes and obesity.",TRUE,4,"The feature 'HBA1C DF glycated haemoglobin genetic risk' is interesting due to its potential novelty. While the relationship between diabetes and gallbladder disease is known, the specific genetic risk associated with glycated hemoglobin and its direct correlation with gallbladder conditions is not well-documented. This suggests a novel area of research that could provide new insights into the genetic predisposition to gallbladder diseases in the context of metabolic health. From a plausibility standpoint, the association is logical. Glycated hemoglobin is a marker of long-term blood glucose levels, and diabetes is a known risk factor for gallbladder disease due to changes in bile composition and gallbladder motility. Therefore, the metabolic disturbances associated with higher HbA1c levels could indeed create conditions favorable for gallstone formation. The weak positive correlation and feature lift suggest a modest but potentially meaningful association that warrants further exploration. Overall, the feature is quite interesting to researchers due to its novelty and plausible biological mechanism linking metabolic and genetic factors to gallbladder disease.",0.002,0.133,0.004,0,1.68,(HBA1C_DF) glycated haemoglobin genetic risk < -3.30,FALSE,"The association between the feature 'HBA1C DF glycated haemoglobin genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not explicitly mentioned in the provided documents. However, it is known that diabetes mellitus is associated with an increased risk of gallstones, and autonomic neuropathy in individuals with diabetes is correlated with a greater number of gallstones. Therefore, the feature 'HBA1C DF glycated haemoglobin genetic risk' is related to the development of gallstones, but it is not a direct risk factor for cholelithiasis or gallbladder disease. However, it is part of the broader risk factors for gallstone formation, which include metabolic derangements such as dyslipidemia, diabetes, obesity, insulin resistance, and diets higher in saturated fats and sugar, and lower in fiber.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Genetic propensity for higher HbA1c (metabolic dysregulation) may inform gallbladder disease risk, offering moderate relevance in assessing overall metabolic burden.",TRUE,3,,,,,,,,,,,,,,,,,,,,,positive
39,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Blood pressure medication",1,"The association between medications for cholesterol, blood pressure, diabetes, and gallbladder diseases such as cholelithiasis (gallstones) is not well-documented in the provided documents. While there are mentions of medications affecting various health conditions, including diabetes and hypertension, there is no direct evidence or established understanding linking these medications specifically to gallbladder diseases. The documents primarily discuss the effects of these medications on cardiovascular health and diabetes management, but do not provide insights into their impact on gallbladder conditions. Therefore, this association can be considered novel as it does not contradict established understanding but rather highlights a potential area for further research.",0,"To determine if there is a plausible explanation for the association between medication for cholesterol, blood pressure, diabetes, or exogenous hormones and gallbladder diseases such as cholelithiasis, we need to consider the known mechanisms of these conditions. Medications for cholesterol (like statins) and blood pressure can influence metabolic processes, which may indirectly affect gallbladder function. For instance, statins have been shown to have effects on cholesterol metabolism, which is directly related to gallstone formation since gallstones are primarily composed of cholesterol. Additionally, diabetes and obesity are risk factors for gallbladder disease, and medications that manage these conditions may alter the risk profile. However, the linear correlation of 0.022 suggests a very weak relationship, indicating that while there may be some connection, it is not strong enough to assert a direct causal link. Therefore, while there are mechanisms that could explain a relationship, the weak correlation suggests that it may not be significant enough to be considered a plausible explanation. Thus, the answer is B.",TRUE,3,"1. **Novelty:** The association between blood pressure medication and gallbladder diseases is not well-documented, making it a novel finding. While there is extensive literature on the effects of these medications on cardiovascular health, their impact on gallbladder conditions is not well-explored. This suggests a potential new area of research.

2. **Plausibility:** There are plausible mechanisms that could explain the association. Blood pressure medications, particularly those affecting metabolic processes, could influence cholesterol metabolism, which is directly related to gallstone formation. However, the correlation is weak (0.022), indicating that while there is a potential connection, it is not strong enough to suggest a direct causal link. This weak correlation undermines the plausibility of a significant relationship.

3. **Usefulness:** The feature could have potential utility in clinical settings if further research substantiates the association. It could inform risk assessments for gallbladder diseases in patients on blood pressure medications. However, given the weak correlation, its immediate practical application is limited.

Overall, the feature is interesting due to its novelty and potential for further research, despite the weak correlation affecting its plausibility and immediate usefulness.",0.022,0,0.007,0.002,1.24,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Blood pressure medication >= 0.50",FALSE,"The association between the feature 'Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones-Blood pressure medication' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is well known. The documents provide information on how certain medications, such as hormone replacement therapy containing estrogen, can increase the risk of gallstone formation by causing increased levels of cholesterol. Additionally, medications like fibrates can block the rate-limiting enzyme 7-alpha-hydroxylase, leading to increased cholesterol and decreased bile acid production, which can contribute to gallstone formation. Furthermore, medications such as ezetimide and a state of insulin resistance can inhibit cholesterol transport into the intestine and intestinal cholesterol absorption, promoting cholesterol synthesis, which is typically downregulated with increased dietary absorption. These mechanisms are well-established and documented in the provided texts.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Weak correlation and no strong evidence linking these meds directly to gallbladder disease; slight practical value for risk stratification.,FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
2,Number of self-reported non-cancer illnesses,1,"The association between the number of self-reported non-cancer illnesses and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the provided literature. While gallbladder diseases are often associated with specific risk factors like obesity, gallstones, and chronic inflammation, the direct correlation with the number of non-cancer illnesses is not explicitly mentioned. Therefore, if this feature shows a positive correlation with gallbladder diseases, it could be considered novel or at least not well-established in current medical understanding. This suggests that further research could provide new insights into the relationship between general health status and gallbladder disease risk, indicating that the feature may indeed be novel.",1,"Cholelithiasis (gallstones) and gallbladder diseases are often associated with various non-cancer illnesses, particularly those related to metabolic and digestive health. The presence of gallstones can lead to conditions such as cholecystitis and cholangitis, which are inflammatory diseases of the gallbladder and bile ducts, respectively. These conditions can be influenced by factors such as obesity, chronic inflammation, and dietary habits, which are also linked to other non-cancer illnesses. The positive linear correlation of 0.045 suggests a weak association, but it indicates that as the number of self-reported non-cancer illnesses increases, there may be a slight increase in the likelihood of gallbladder disease. This could be due to shared risk factors such as obesity, metabolic syndrome, or chronic inflammation that affect both gallbladder health and the prevalence of other non-cancer illnesses. Therefore, it makes sense to consider that there is a plausible explanation for this relationship based on known mechanisms of disease and shared risk factors.",TRUE,4,"The feature 'Number of self-reported non-cancer illnesses' is evaluated for its novelty and plausibility in predicting gallbladder diseases. 

**Novelty:** The association between the number of non-cancer illnesses and gallbladder diseases is not explicitly documented in existing literature, which typically focuses on specific risk factors like obesity and metabolic syndrome. This suggests that the feature could be novel, as it highlights a broader health status indicator rather than specific conditions. This novelty is further supported by the fact that the feature shows a positive correlation with gallbladder diseases, which is not a well-established link.

**Plausibility:** The plausibility of this feature is supported by the shared risk factors between gallbladder diseases and other non-cancer illnesses, such as chronic inflammation, obesity, and metabolic issues. These shared risk factors provide a logical explanation for the observed correlation. Additionally, having multiple non-cancer illnesses could indicate a general decline in health, which might predispose individuals to gallbladder diseases due to systemic inflammation or metabolic imbalances.

**Usefulness:** This feature could be useful in a clinical setting as it provides a broader perspective on a patient's health status. It could help identify individuals at higher risk for gallbladder diseases, allowing for earlier interventions or monitoring. 

Overall, the feature is interesting due to its potential novelty and plausible biological underpinnings, as well as its practical utility in clinical risk assessment.",0.045,0,0.008,0.006,1.62,Number of self-reported non-cancer illnesses >= 3.10,TRUE,"The relationship between the feature 'Number of self-reported non-cancer illnesses' and the target disease 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not explicitly mentioned in the provided documents. However, the documents do mention that certain conditions such as diabetes, obesity, and hyperlipidemia increase the risk of gallstone formation and complications. Additionally, the presence of chronic illnesses such as diabetes and hyperlipidemia can lead to reduced gallbladder wall contractility, which may contribute to the development of gallstones. Furthermore, the documents also mention that patients with drastic weight loss or fasting have a higher chance of gallstones secondary to biliary stasis. These associations suggest that non-cancer illnesses may have an indirect impact on the development of gallstone disease. However, the specific relationship between the 'Number of self-reported non-cancer illnesses' and the target disease is not explicitly stated.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,General comorbidity count can reflect overall health burden; moderately useful for identifying higher-risk patients.,TRUE,3,,,,,,,,,,,,,,,,,,,,,positive
38,SHBG,1,"The feature 'SHBG' (Sex Hormone Binding Globulin) is primarily known for its role in transporting sex steroids and its involvement in various endocrine disorders. However, its direct association with gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis is not well-documented in the literature. The question indicates a negative correlation between SHBG and these gallbladder diseases, which is not a commonly discussed relationship in existing medical knowledge. Therefore, this suggests that the association may be novel or at least not widely recognized. Given that the relationship is not established in current understanding, it could provide new insights into the pathophysiology of gallbladder diseases or contradict existing beliefs about the role of SHBG in these conditions. Thus, the conclusion is that this association is indeed novel or provides new insights.",0,"Sex Hormone Binding Globulin (SHBG) is primarily involved in the transport of sex hormones and is produced mainly in the liver. While there is some evidence suggesting that hormonal levels can influence gallbladder disease, the negative correlation of -0.013 indicates a very weak relationship between SHBG levels and the diseases in question (cholelithiasis, gallbladder disease, cholecystitis, and cholangitis). The mechanisms linking SHBG to gallbladder diseases are not well established, and the existing literature does not provide a strong basis for a direct association. Therefore, it is reasonable to conclude that there is no plausible explanation for a significant relationship between SHBG and these gallbladder-related conditions based on current understanding.",TRUE,3,"The feature 'SHBG' (Sex Hormone Binding Globulin) is primarily associated with the transport of sex hormones and is produced in the liver. While SHBG's role in endocrine disorders is well-known, its direct association with gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis is not well-documented in the literature, making this association potentially novel. The negative correlation observed suggests that higher SHBG levels might be associated with a lower risk of these diseases, which is not a commonly discussed relationship. This could provide new insights into the pathophysiology of gallbladder diseases, suggesting a novel area of research. However, the plausibility of this association is weak, as the mechanisms linking SHBG to gallbladder diseases are not well established. The negative correlation is also very weak (-0.013), indicating that even if there is an association, it might not be clinically significant. Given these points, while the association is novel, its plausibility and potential impact are limited, making it moderately interesting.",-0.013,0,0.008,0,1.07,SHBG >= 4.00,FALSE,"The feature 'SHBG' is related to the regulation of cholesterol levels in the body. SHBG (Sex Hormone-Binding Globulin) is a protein that binds to sex hormones, including testosterone and estrogen, and regulates their activity. In the context of gallbladder disease, SHBG is not directly mentioned in the provided documents as a risk or protective factor. However, the documents do discuss the role of sex hormones, particularly estrogen, in increasing the risk of gallbladder disease. Estrogen has been shown to increase bile cholesterol and decrease gallbladder contractility, which can lead to the formation of gallstones. Therefore, while SHBG is not directly mentioned, its role in regulating sex hormones and their impact on gallbladder disease is related to the development of gallstones and cholelithiasis.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Hormone-binding protein with uncertain gallbladder link; limited applicability to everyday risk prediction or management.,FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
21,Arm fat percentage (left),1,"The association between 'Arm fat percentage' and conditions such as cholelithiasis, gallstones, gallbladder disease, cholecystitis, or cholangitis is not well-documented in the existing literature. While obesity and body fat distribution are known risk factors for gallbladder diseases, specific correlations with arm fat percentage have not been extensively studied or established. Therefore, if there is a positive correlation found, it could be considered novel and may provide new insights into the risk factors for these diseases. However, without specific studies directly linking arm fat percentage to these conditions, it remains uncertain whether this association contradicts established understanding or simply adds to the complexity of risk factors. Thus, it leans towards being novel.",0,"The relationship between 'Arm fat percentage' and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis can be considered in the context of obesity and its known associations with gallbladder disease. Higher body fat percentages, including localized fat such as arm fat, can contribute to an increased risk of developing gallstones due to factors like altered bile composition and increased cholesterol levels. However, the linear correlation of 0.043 indicates a very weak positive relationship, suggesting that while there may be some association, it is not strong enough to establish a clear mechanism. Therefore, while obesity is a known risk factor for gallbladder disease, the specific association with arm fat percentage lacks a strong, direct mechanism. Thus, the answer is B, as the weak correlation does not provide a strong basis for a plausible explanation.",TRUE,3,"1. **Novelty:** The relationship between arm fat percentage and gallbladder diseases is not well-documented, making it a novel area of investigation. While obesity is a known risk factor for gallbladder diseases, the specific contribution of arm fat percentage has not been extensively studied. This suggests that the feature could provide new insights into the distribution of body fat and its impact on gallbladder health, making it interesting from a novelty perspective.

2. **Plausibility:** The plausibility of this feature is moderate. While obesity and increased body fat are known risk factors for gallbladder diseases, the specific role of arm fat is less clear. The weak correlation suggests that while there may be an association, it is not strong enough to establish a direct causal mechanism. However, it is plausible that localized fat deposits could reflect overall body fat distribution, which is a risk factor for gallbladder disease.

3. **Usefulness:** If further research supports the association, arm fat percentage could potentially be used as an additional marker for assessing gallbladder disease risk, especially in cases where traditional measures like BMI are not as informative.

Overall, the feature is interesting due to its novelty and potential implications for understanding body fat distribution's role in gallbladder diseases, despite the weak correlation and unclear biological mechanism.",0.043,0,0.081,0.001,2.05,Arm fat percentage (left) >= 2.90,TRUE,"The association between 'Arm fat percentage' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not directly related. The risk factors for cholelithiasis and gallbladder disease are more related to metabolic, environmental, and genetic factors, such as obesity, high-fat diet, and genetic predisposition. Arm fat percentage is not a known risk factor for gallbladder disease. However, obesity, which is related to arm fat percentage, is a known risk factor for gallbladder disease. Therefore, the association is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"While obesity and fat distribution matter, arm fat percentage alone is not a strong or standard marker for gallbladder disease risk.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
37,(CAD) coronary artery disease genetic risk,1,"The association between genetic risk factors for coronary artery disease (CAD) and gallbladder diseases such as cholelithiasis (gallstones) is not well-documented in the literature. While CAD has a significant genetic component, gallbladder diseases are typically influenced by factors such as diet, obesity, and metabolic syndrome rather than direct genetic predisposition. The negative correlation mentioned suggests that higher genetic risk for CAD may be associated with a lower incidence of gallbladder diseases, which is counterintuitive and not supported by existing research. Therefore, this association can be considered novel as it challenges established understanding and does not align with the known risk factors for gallbladder diseases. Thus, it provides new insights into the relationship between these two conditions.",0,"Coronary artery disease (CAD) and gallbladder diseases such as cholelithiasis (gallstones) and cholecystitis are both influenced by various risk factors, including diet, obesity, and metabolic syndrome. However, the mechanisms underlying CAD primarily involve atherosclerosis and cardiovascular risk factors, while gallbladder diseases are often related to bile composition and gallstone formation. The negative correlation of -0.002 suggests that there is no significant linear relationship between CAD genetic risk and gallbladder diseases. Given the distinct pathophysiological mechanisms and risk factors for these two conditions, it is unlikely that there is a direct or plausible explanation for a relationship between CAD genetic risk and gallbladder diseases. Therefore, the answer is B.",TRUE,3,"The feature 'CAD coronary artery disease genetic risk' is evaluated for its association with gallbladder diseases. In terms of novelty, this association is indeed novel because there is limited literature linking CAD genetic risk directly with gallbladder diseases. Typically, gallbladder diseases are associated with factors like obesity and diet, while CAD is linked to atherosclerosis and cardiovascular risk factors. The negative correlation observed (-0.002) is counterintuitive, suggesting that a higher genetic risk for CAD might correlate with a lower incidence of gallbladder diseases. This challenges existing understanding and could stimulate new research questions, making it novel. However, in terms of plausibility, the association lacks a clear biological mechanism. CAD and gallbladder diseases have distinct pathophysiologies, and without a known pathway linking CAD genetic risk to gallbladder disease incidence, the association seems implausible. Therefore, while the feature is novel, its lack of plausibility limits its overall interest. Given these considerations, the feature is somewhat interesting due to its novelty but not highly so due to the lack of plausible explanation.",-0.002,0.239,0.012,0.001,1.08,(CAD) coronary artery disease genetic risk < -2.00,FALSE,"The relationship between CAD coronary artery disease genetic risk and Cholelithiasis or Gallstone or Gallbladder disease or cholecystitis or Cholangitis is not directly related. However, there is an association between the two conditions. Studies have shown that individuals with gallstones have a higher risk of cardiovascular disease, including coronary artery disease. The pathophysiology of gallstones involves an imbalance between the synthesis, dietary absorption, and recirculation of cholesterol, which can lead to hypercholesterolemia and coronary artery disease. Additionally, gallstones can cause inflammation and oxidative stress, which can contribute to the development of atherosclerosis and CAD. Therefore, while the relationship is not direct, there is an indirect association between CAD genetic risk and the development of gallstones or gallbladder disease.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Minimal or no direct gallbladder linkage; offers negligible value for gallbladder disease assessment.,FALSE,1,,,,,,,,,,,,,,,,,,,,,negative
36,"Complications of cardiac/vascular device, implant, and graft",1,"The relationship between complications of cardiac vascular devices and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the literature. While both areas involve medical complications, they typically pertain to different organ systems and types of medical interventions. The documents provided do not establish a direct link between complications arising from cardiac/vascular devices and gallbladder diseases. Therefore, the assertion that there is a positive correlation between these two features is novel and not supported by existing knowledge. This suggests that the feature may provide new insights into potential complications or interactions between these two medical areas, which have not been previously explored or documented. Thus, it can be concluded that this association is indeed novel.",0,"To determine if there is a plausible explanation for the association between 'Complications of cardiac vascular device implant and graft' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the mechanisms involved in both conditions. Complications from cardiac vascular devices often involve infections, inflammatory responses, and the body's reaction to foreign materials. On the other hand, gallbladder diseases, particularly cholecystitis and cholangitis, are primarily related to the presence of gallstones, which can cause blockages and inflammation in the biliary system. While both conditions involve inflammation, they are largely independent processes. The positive linear correlation of 0.01 suggests a very weak relationship, which is not strong enough to imply a direct or meaningful connection. Therefore, there is no strong or plausible mechanism that links complications from cardiac devices directly to gallbladder diseases. Thus, the answer is B.",TRUE,3,"The feature 'Complications of cardiac vascular device implant and graft' in relation to gallbladder diseases is interesting primarily due to its novelty. The association between these two medical areas is not well-documented, suggesting that this could be a new area of research that has not been previously explored. From a novelty perspective, this is intriguing because it challenges the conventional understanding that these complications and gallbladder diseases are unrelated due to their involvement in different organ systems. However, from a plausibility standpoint, the association is weak and lacks a clear biological mechanism linking the two. Cardiac device complications typically involve cardiovascular and systemic issues, while gallbladder diseases are more localized to the biliary system. The weak positive correlation (0.01) further suggests that any relationship is likely coincidental rather than causal. Despite the lack of a plausible mechanism, the novelty of the association could still be of interest to researchers looking to explore unexpected links between different medical conditions. Therefore, while the feature is novel, its practical utility or biological plausibility is limited, which slightly diminishes its overall interest level.",0.01,0.004,0.001,0.001,2.35,"11.00 <= Complications of cardiac/vascular device, implant, and graft < 14.00",TRUE,"The association between 'Complications of cardiac/vascular device, implant, and graft' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not explicitly mentioned in the provided documents. However, it can be inferred that complications of cardiac/vascular device, implant, and graft may be related to the development of gallstones or gallbladder disease due to the underlying conditions that lead to these complications, such as cardiovascular disease, diabetes, and hypertension. For instance, studies show that individuals with gallstones have a higher risk of hypertension, diabetes mellitus, atrial fibrillation, hyperlipidemia, coronary artery disease, and cerebrovascular disease. Therefore, it is plausible that complications of cardiac/vascular device, implant, and graft may be a risk factor for gallbladder disease.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Unrelated complications that do not meaningfully inform gallbladder disease risk or management.,FALSE,1,,,,,,,,,,,,,,,,,,,,,positive
41,LDL direct Blood biochemistry,1,"The relationship between LDL cholesterol levels and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the literature. While high LDL levels are generally associated with cardiovascular diseases, the specific correlation with gallbladder diseases is less clear. The assertion that there is a negative correlation between LDL levels and gallbladder diseases suggests that higher LDL might be protective or that lower LDL levels could be associated with gallbladder issues, which contradicts the common understanding that high cholesterol is a risk factor for various diseases. This perspective is not widely recognized in existing research, indicating that it could be considered novel or at least surprising. Therefore, the feature does provide new insights or contradicts established understanding.",0,"Cholelithiasis (gallstones) and gallbladder diseases are primarily related to the composition and metabolism of bile, which includes cholesterol. High levels of low-density lipoprotein (LDL) cholesterol are typically associated with cardiovascular diseases rather than gallbladder diseases. The negative correlation of -0.003 suggests that as LDL levels increase, the incidence of gallbladder diseases does not significantly change, indicating no direct relationship. While there may be some indirect connections through metabolic syndrome or obesity, the primary mechanisms of gallstone formation are more closely related to bile composition and gallbladder function rather than LDL levels. Therefore, it does not make sense to associate LDL direct blood biochemistry with gallbladder diseases based on known mechanisms or theories.",TRUE,3,"The feature 'LDL direct Blood biochemistry' being negatively correlated with gallbladder diseases is intriguing because it challenges the common understanding that higher cholesterol levels, including LDL, are associated with increased disease risk. This negative correlation suggests a protective role or an inverse relationship, which is not well-documented in the literature for gallbladder diseases. Novelty-wise, this is interesting as it contradicts established beliefs and could lead to new research avenues. However, from a plausibility standpoint, the connection is weak because gallbladder diseases are more directly related to bile composition rather than blood LDL levels. Therefore, while the feature is novel, its practical usefulness and biological plausibility are questionable. This makes it moderately interesting as a research hypothesis but not strongly compelling without further evidence.",-0.003,0.023,0.002,0,1.52,#NAME?,FALSE,"The association between LDL direct Blood biochemistry and Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis is well known. LDL cholesterol is a risk factor for gallstone formation, and high levels of LDL cholesterol can lead to supersaturation of bile with cholesterol, which is a common cause of cholesterol gallstones. This is explained in Document [8] and Document [9].",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"LDL is central to cholesterol metabolism, but weak/negative correlation here diminishes its direct clinical utility in gallbladder disease.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
6,A09.9 - Gastroenteritis and colitis of unspecified origin,1,"The association between 'A09.9 - Gastroenteritis and colitis of unspecified origin' and conditions like 'Cholelithiasis', 'Gallstone', 'Gallbladder disease', 'Cholecystitis', or 'Cholangitis' is not well-documented in the literature. While gastroenteritis and colitis are primarily related to infections or inflammatory processes in the gastrointestinal tract, gallbladder diseases are typically associated with bile duct obstructions or gallstones. The documents reviewed do not provide a direct link or established correlation between these two categories. Therefore, the suggestion that there is a positive correlation between unspecified gastroenteritis and gallbladder diseases is novel and not supported by existing literature, which primarily treats these conditions separately. This indicates that the feature may provide new insights into the relationship between gastrointestinal and biliary diseases, suggesting a need for further investigation into this potential association.",1,"To determine if there is a plausible explanation for the association between 'A09.9 - Gastroenteritis and colitis of unspecified origin' and conditions like 'Cholelithiasis', 'Gallstone', 'Gallbladder disease', 'Cholecystitis', or 'Cholangitis', we need to consider the underlying mechanisms of these conditions. Gastroenteritis and colitis can lead to gastrointestinal disturbances, which may affect the gallbladder's function and bile production. Inflammation or infection in the gastrointestinal tract can potentially influence the formation of gallstones or exacerbate gallbladder disease due to altered bile composition or motility. Additionally, conditions that cause gastrointestinal upset may lead to changes in dietary habits or fluid intake, which can also impact gallbladder health. Therefore, while the linear correlation is low (0.01), there is a theoretical basis for a relationship between gastrointestinal conditions and gallbladder diseases, suggesting that the association could be plausible. Thus, the answer is A.",TRUE,4,"1. **Novelty:** The association between 'A09.9 - Gastroenteritis and colitis of unspecified origin' and gallbladder-related diseases is not well-documented in existing literature. Typically, gastroenteritis and colitis are linked to infections or inflammation in the gastrointestinal tract, while gallbladder diseases are associated with bile duct issues or gallstones. This lack of direct documentation suggests a novel potential relationship that may warrant further exploration.

2. **Plausibility:** Although there is no established direct link, there are plausible mechanisms that could explain the association. Gastrointestinal disturbances from gastroenteritis or colitis might affect bile production or gallbladder function, potentially influencing gallstone formation or exacerbating gallbladder disease. Changes in diet or hydration due to gastrointestinal issues could also impact gallbladder health. These theoretical pathways provide a plausible basis for the observed correlation.

3. **Usefulness:** If the association is validated, it could have clinical implications, such as monitoring patients with recurrent gastroenteritis for gallbladder issues or adjusting dietary recommendations.

Given the novelty and plausible biological mechanisms, this feature is interesting for further research, even though the correlation is weak. It opens up new avenues for understanding the interplay between gastrointestinal and biliary conditions.",0.01,0,0.003,0.001,2.13,A09.9 - Gastroenteritis and colitis of unspecified origin >= 8.60,TRUE,"The feature 'A09.9 - Gastroenteritis and colitis of unspecified origin' is related to gastrointestinal issues, but it is not directly linked to the development of cholelithiasis, gallstones, or gallbladder disease. The primary risk factors for these conditions include genetic predisposition, obesity, female sex, age, and certain medical conditions such as inflammatory bowel disease. While gastroenteritis and colitis of unspecified origin may share some underlying mechanisms with these conditions, such as inflammation and immune system dysregulation, the specific relationship between this feature and the target diseases is not well established or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"GI inflammation might overlap with biliary disease symptoms, but correlation is weak and not routinely actionable.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
15,(LDL_SF) low density lipoprotein cholesterol genetic risk,1,"The association between low-density lipoprotein (LDL) cholesterol genetic risk and gallbladder diseases such as cholelithiasis, gallstones, cholecystitis, or cholangitis is not well-documented in the current literature. While high levels of LDL cholesterol are generally associated with cardiovascular diseases, the relationship with gallbladder diseases is less clear. The negative correlation mentioned suggests that higher genetic risk for LDL cholesterol may be associated with a lower incidence of gallbladder diseases, which contradicts the established understanding that high cholesterol levels can contribute to gallstone formation. Therefore, this association could be considered novel as it provides new insights that challenge the traditional view of cholesterol's role in gallbladder disease.",0,"To determine if there is a plausible explanation for the association between low-density lipoprotein (LDL) cholesterol genetic risk and gallbladder diseases such as cholelithiasis, we need to consider the known mechanisms of both LDL cholesterol and gallbladder disease. Elevated LDL cholesterol is primarily associated with cardiovascular diseases and atherosclerosis, while gallbladder diseases are often related to cholesterol metabolism and the formation of gallstones. Gallstones can form when there is an imbalance in the substances that make up bile, including cholesterol. A negative correlation of -0.007 suggests that as LDL cholesterol genetic risk increases, the incidence of gallbladder disease does not increase significantly, which may imply that high LDL cholesterol does not directly contribute to gallbladder disease. Instead, other factors such as bile composition, obesity, and dietary habits may play a more significant role in gallbladder disease. Therefore, the lack of a strong positive correlation and the nature of the diseases suggest that there is no direct or plausible mechanism linking LDL cholesterol genetic risk to gallbladder diseases. Thus, the answer is B.",TRUE,4,"The feature 'LDL SF' low density lipoprotein cholesterol genetic risk shows a negative correlation with gallbladder diseases, which is intriguing because it contradicts the traditional understanding that high cholesterol levels can contribute to gallstone formation. This suggests a novel insight, as the relationship between genetic risk for LDL cholesterol and gallbladder diseases is not well-documented. From a novelty perspective, this association challenges existing beliefs and could open new avenues for research. In terms of plausibility, while high LDL cholesterol is linked with cardiovascular issues, the mechanisms linking it to gallbladder disease are less clear. Gallstones are often related to cholesterol metabolism, but the negative correlation implies that genetic predisposition to higher LDL cholesterol might not directly lead to gallbladder issues, suggesting other factors like bile composition or dietary habits might be more influential. This makes the feature somewhat plausible but not strongly supported by existing mechanisms. Overall, the feature is interesting due to its novelty and potential to spur further investigation into the genetic and metabolic pathways involved in gallbladder diseases.",-0.007,0,0.016,0,1.15,(LDL_SF) low density lipoprotein cholesterol genetic risk < -3.30,FALSE,"The association between low-density lipoprotein (LDL) cholesterol genetic risk and gallstone disease is well established. LDL cholesterol is a major risk factor for the development of atherosclerosis, which is a known risk factor for gallstone disease. The genetic risk of LDL cholesterol is associated with an increased risk of gallstone formation, as it contributes to the supersaturation of bile with cholesterol, leading to the formation of cholesterol stones. This is supported by the fact that genetic factors account for 25% of the risk of gallstone formation, and a single nucleotide polymorphism of the gene encoding the hepatic cholesterol transporter ABCG5/G8 has been found in 21% of patients with gallstones. Therefore, the association between LDL cholesterol genetic risk and gallstone disease is well known and explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Genetic predisposition to elevated LDL could affect cholesterol gallstones, but evidence is too weak for robust clinical use.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
22,Vitamin D,1,"The relationship between Vitamin D and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis has been explored in various studies. Document [6] mentions that individuals with Erythropoietic protoporphyria (EPP) are at increased risk for gallstones, and it notes a potential link between Vitamin D deficiency and gallbladder disease. Document [24] discusses Vitamin D deficiency in the context of gallbladder mucocele in dogs, suggesting a possible role of Vitamin D in gallbladder health. However, the overall consensus in the literature does not strongly establish a direct negative correlation between Vitamin D levels and these gallbladder diseases. While there are associations noted, they do not appear to be widely recognized or established in the medical community, indicating that the relationship may not be well-documented. Therefore, the assertion that Vitamin D has a negative correlation with gallbladder diseases is somewhat surprising and not well-established, suggesting that it could be considered novel or providing new insights into the understanding of these conditions.",0,"Vitamin D is known to play a role in various bodily functions, including immune regulation and calcium metabolism. Some studies suggest that vitamin D deficiency may be associated with an increased risk of gallstone formation (cholelithiasis) and gallbladder diseases. However, the linear correlation of -0.019 indicates a very weak negative relationship, suggesting that as vitamin D levels decrease, the incidence of these gallbladder diseases does not significantly increase. This weak correlation may imply that while vitamin D has some role in gallbladder health, it is not a strong or direct factor in the development of gallstones or related diseases. Therefore, while there may be some theoretical basis for a relationship, the evidence does not strongly support a significant association. Thus, the answer is B, as the weak correlation does not provide a strong basis for a plausible explanation of a direct relationship between vitamin D and gallbladder diseases.",TRUE,3,"The feature 'Vitamin D' in relation to gallbladder diseases presents a somewhat novel insight. While there are some studies suggesting a potential link between Vitamin D deficiency and gallbladder diseases, this association is not widely recognized or established in the medical community. This indicates a level of novelty, as it challenges or adds to the existing body of knowledge. However, the correlation is very weak (-0.019), suggesting that the practical significance of this finding is limited. From a plausibility standpoint, Vitamin D is involved in various bodily functions, including immune regulation and calcium metabolism, which could theoretically influence gallbladder health. However, the weak correlation implies that Vitamin D is not a strong or direct factor in these diseases. Given these considerations, the feature is somewhat interesting due to its novelty, but the weak correlation limits its practical utility and plausibility as a significant predictor of gallbladder diseases.",-0.019,0,0.012,0,1.21,#NAME?,TRUE,"The association between Vitamin D and the target diseases is not directly related to the formation of gallstones or gallbladder disease. However, Vitamin D deficiency has been linked to an increased risk of cardiovascular disease, which is also associated with gallbladder disease. But there is no direct evidence that Vitamin D has a significant impact on the formation of gallstones or gallbladder disease. Therefore, the association between Vitamin D and the target diseases is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Possible minor role in metabolism/inflammation, but negative correlation is weak and not strongly actionable in gallbladder care.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
13,Sleep - Overall average,1,"The relationship between sleep patterns and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not extensively documented in the current medical literature. While there are known risk factors for gallbladder diseases, including diet and obesity, the specific impact of sleep quality or quantity on these conditions has not been a primary focus of research. Therefore, if a positive correlation between 'Sleep - Overall average' and these gallbladder diseases is observed, it could be considered novel or surprising, as it may suggest a previously unrecognized risk factor or mechanism. This could provide new insights into the management or prevention of gallbladder diseases. Thus, the association could be seen as novel, as it contradicts the established understanding that primarily focuses on dietary and metabolic factors without significant emphasis on sleep.",0,"To determine if there is a plausible explanation for the relationship between 'Sleep - Overall average' and the diseases related to the biliary system (Cholelithiasis, Gallstone, Gallbladder disease, Cholecystitis, Cholangitis), we need to consider the known mechanisms of these diseases and how sleep might influence or correlate with them. Sleep disturbances can affect various physiological processes, including immune function, inflammation, and pain perception. Chronic sleep deprivation may lead to increased inflammation, which could exacerbate conditions like cholecystitis or cholangitis. Additionally, poor sleep quality may influence dietary habits, potentially leading to obesity and increased risk of gallstone formation. However, the linear correlation of 0.014 is very weak, suggesting that while there may be some relationship, it is not strong enough to establish a clear mechanism. Therefore, while there are some theoretical connections, the weak correlation does not strongly support a direct relationship. Thus, the answer is B, as the weak correlation does not provide a strong basis for a plausible explanation.",TRUE,4,"1. **Novelty:** The relationship between sleep patterns and gallbladder diseases is not well-documented in existing literature, which primarily focuses on dietary and metabolic factors. The identification of sleep as a potential risk factor is novel, as it suggests a previously unrecognized mechanism that could influence gallbladder disease development. This provides a new perspective that could lead to further research into how sleep impacts these diseases, making it a novel finding.

2. **Plausibility:** While the correlation is weak, there are plausible biological mechanisms that could explain a relationship between sleep and gallbladder diseases. Sleep disturbances can lead to increased inflammation and affect dietary habits, both of which are relevant to gallbladder disease risk. Although the correlation is not strong, the theoretical connections through inflammation and metabolic changes provide a plausible basis for further investigation.

3. **Usefulness:** If further research confirms this association, it could have practical applications in clinical settings, such as recommending sleep improvements as part of a holistic approach to managing or preventing gallbladder diseases. However, due to the weak correlation, its immediate utility is limited until more robust evidence is available.

Overall, the feature is interesting due to its novelty and potential biological plausibility, despite the weak correlation.",0.014,0.001,0.012,0,1.36,1.50 <= Sleep - Overall average < 4.80,TRUE,"The association between 'Sleep - Overall average' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not directly mentioned in the provided documents. However, the documents do mention that autonomic neuropathy in individuals with diabetes is correlated with a greater number of gallstones, and that diabetes is associated with an increased risk of gallstones. Additionally, the documents mention that obesity, which is related to sleep disorders, is a risk factor for gallstones. However, the specific relationship between 'Sleep - Overall average' and the target disease is not explicitly stated. Therefore, the association is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,General health factor with unclear and weak link to gallbladder disease; low direct utility for clinical decisions.,FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
23,(AD) alzheimer's disease genetic risk,1,"The association between Alzheimer's disease (AD) genetic risk factors and gallbladder diseases such as cholelithiasis (gallstones) is not well-documented in the literature. While there are established genetic risk factors for Alzheimer's disease, such as the APOE ε4 allele, the relationship between these genetic factors and gallbladder diseases is not commonly discussed. The documents provided do not indicate a direct link or correlation between Alzheimer's disease genetic risk and gallbladder diseases, suggesting that this association may be novel or not widely recognized. Furthermore, the mention of a negative correlation implies that as genetic risk for Alzheimer's increases, the incidence of gallbladder disease decreases, which contradicts the established understanding that genetic risk factors typically correlate positively with disease incidence. Therefore, this feature does provide new insights and could be considered novel.",0,"To determine if there is a plausible explanation for the association between 'AD Alzheimer's disease genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the known mechanisms of both conditions. Alzheimer's disease (AD) is primarily a neurodegenerative disorder characterized by genetic risk factors such as the APOE4 allele, which is linked to lipid metabolism and amyloid plaque formation in the brain. On the other hand, gallbladder diseases, including cholelithiasis and cholecystitis, are often related to metabolic factors, particularly those involving cholesterol and bile acid metabolism. While both conditions involve metabolic processes, the specific genetic risk factors for AD do not directly correlate with the pathophysiology of gallbladder diseases. The negative correlation of -0.005 suggests that as one condition increases, the other does not necessarily follow, indicating a lack of direct relationship. Therefore, there is no strong theoretical or mechanistic basis to suggest that genetic risk for AD would be associated with gallbladder diseases. Thus, the answer is B.",TRUE,3,"The feature 'AD Alzheimer's disease genetic risk' is evaluated for its association with gallbladder diseases. In terms of novelty, this association is not well-documented in existing literature, making it a novel finding. Alzheimer's disease is primarily associated with neurodegenerative processes, while gallbladder diseases are linked to metabolic processes. The negative correlation suggests that a higher genetic risk for Alzheimer's might be associated with a lower incidence of gallbladder diseases, which is counterintuitive and not supported by known biological mechanisms. This lack of a direct mechanistic link reduces the plausibility of the association. However, the novelty of the finding could spur further research into potential indirect pathways or shared metabolic factors that have not been explored. Despite the low plausibility, the novelty aspect makes it somewhat interesting for researchers who might want to explore unexplored genetic or metabolic links between these conditions. Therefore, while the feature is not highly plausible, its novelty gives it some interest value.",-0.005,0.003,0.012,0,1.59,0.77 <= (AD) alzheimer's disease genetic risk < 0.77,TRUE,"The association between AD (Alzheimer's disease) genetic risk and Cholelithiasis or Gallstone or Gallbladder disease or Cholecystitis or Cholangitis is not directly related. The provided documents do not explicitly mention a connection between AD genetic risk and the development of gallstones or gallbladder disease. However, there is a mention of insulin resistance and diabetes mellitus being associated with an increased risk of gallstones, and insulin resistance is linked to AD. But this is an indirect association. Therefore, the answer is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,No recognized mechanistic overlap with gallbladder disease; offers no practical predictive or management utility.,FALSE,1,,,,,,,,,,,,,,,,,,,,,negative
14,(SCZ) schizophrenia genetic risk,1,"The association between schizophrenia (SCZ) genetic risk and gallbladder diseases such as cholelithiasis, gallstones, cholecystitis, or cholangitis is not well-documented in the current literature. While there is extensive research on the genetic basis of schizophrenia and its comorbidities, the specific link to gallbladder diseases is not established. The negative correlation suggests that higher genetic risk for SCZ may be associated with lower incidence or severity of gallbladder diseases, which is counterintuitive and not supported by existing knowledge. Therefore, this association can be considered novel as it provides new insights that contradict established understanding of the relationship between psychiatric disorders and physical health conditions. Thus, the answer is A.",0,"To determine if there is a plausible explanation for the association between 'SCZ schizophrenia genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the known mechanisms and theories regarding both conditions. Schizophrenia (SCZ) is primarily a neuropsychiatric disorder with a strong genetic component, while gallbladder diseases are typically related to metabolic and dietary factors. The negative linear correlation of -0.004 suggests that there is no significant relationship between the genetic risk for schizophrenia and gallbladder diseases. Furthermore, the literature does not provide evidence of a direct biological or genetic link between schizophrenia and gallbladder diseases. Therefore, it is reasonable to conclude that there is no plausible explanation for this relationship, as the two conditions arise from different pathophysiological mechanisms and risk factors.",TRUE,4,"The feature 'SCZ schizophrenia genetic risk' in relation to gallbladder diseases is intriguing due to its novelty. There is no established literature linking genetic risk for schizophrenia with gallbladder conditions, making this association novel. The negative correlation is unexpected, as schizophrenia and gallbladder diseases are typically not considered related through shared genetic or biological pathways. Schizophrenia is a neuropsychiatric disorder with genetic and environmental influences, while gallbladder diseases are more associated with metabolic and dietary factors. The lack of a plausible biological mechanism connecting these conditions further emphasizes the novelty of this finding. However, the absence of a clear biological explanation also limits its immediate utility, as it does not suggest a direct clinical application or intervention. Despite this, the novelty of the association could stimulate further research into potential indirect links or shared pathways that are not yet understood. Therefore, while the feature is novel, its practical utility remains limited until further research is conducted.",-0.004,0.017,0.006,0,1.85,0.95 <= (SCZ) schizophrenia genetic risk < 0.95,TRUE,"The relationship between schizophrenia genetic risk and gallbladder disease is not well established in the provided documents. The documents primarily focus on the risk factors for gallbladder disease, such as cholelithiasis, obesity, female gender, and genetic predisposition, but do not mention schizophrenia genetic risk as a known risk factor for gallbladder disease. Therefore, the association between the feature 'SCZ schizophrenia genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Psychiatric genetic risk does not meaningfully inform gallbladder disease risk or management.,FALSE,1,,,,,,,,,,,,,,,,,,,,,negative
20,Started insulin within one year diagnosis of diabetes_No,1,"The association between starting insulin within one year of diabetes diagnosis and gallbladder diseases such as cholelithiasis, gallstones, cholecystitis, or cholangitis is not well-documented in the current literature. While diabetes is a known risk factor for gallstone formation, the specific correlation with the timing of insulin initiation is not commonly discussed. Therefore, this feature could be considered novel as it may provide new insights into the relationship between diabetes management and gallbladder disease. The existing literature primarily focuses on the general risk factors for gallstones and does not specifically address the impact of insulin therapy timing. Thus, this association could potentially contradict or expand upon established understanding of diabetes and gallbladder disease interactions.",1,"To determine if there is a plausible explanation for the association between 'Started insulin within one year diagnosis of diabetes' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the known mechanisms linking diabetes and gallbladder diseases. Diabetes, particularly type 2 diabetes, is associated with obesity and metabolic syndrome, which are risk factors for gallstone formation. Insulin resistance can lead to changes in bile composition, increasing the likelihood of cholesterol gallstone formation. Additionally, individuals with diabetes may have altered gallbladder motility, which can contribute to gallbladder disease. Therefore, the positive correlation of 0.014 suggests a weak but existing relationship, likely due to these underlying mechanisms linking diabetes and gallbladder conditions. Thus, it makes sense to associate the two based on these known interactions.",TRUE,3,"The feature 'Started insulin within one year diagnosis of diabetes' is evaluated for its novelty and plausibility in relation to gallbladder diseases. 

1. **Novelty:** The association between early insulin initiation and gallbladder diseases is not well-documented in existing literature. While diabetes is a known risk factor for gallbladder diseases, the specific timing of insulin initiation as a factor is not commonly explored. This suggests a novel angle that could provide new insights into diabetes management and its implications on gallbladder health.

2. **Plausibility:** The plausibility of this association can be reasoned through known mechanisms. Diabetes is linked to metabolic changes that can affect gallbladder function, such as altered bile composition and gallbladder motility. Insulin resistance, common in diabetes, could exacerbate these issues. However, the direct link between the timing of insulin initiation and gallbladder disease is less clear. While plausible, the association is not strongly supported by current biological understanding, making it somewhat speculative.

3. **Usefulness:** If this feature is validated, it could inform clinical decisions regarding the timing of insulin therapy in diabetic patients to potentially mitigate gallbladder disease risk. However, given the weak correlation, its practical utility might be limited without further research.

Overall, the feature is interesting due to its novelty and potential implications, but the weak correlation and speculative nature of the biological link limit its impact.",0.014,0,0.001,0,1.17,Started insulin within one year diagnosis of diabetes_No >= 0.50,FALSE,"The association between 'Started insulin within one year diagnosis of diabetes' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not explicitly mentioned in the provided documents. However, it can be inferred that diabetes is a risk factor for gallbladder disease, including cholelithiasis, gallstones, and gallbladder disease. The documents mention that people with diabetes have an increased risk of gallstone formation and complications, and that autonomic neuropathy in individuals with diabetes is correlated with a greater number of gallstones. Therefore, it is reasonable to assume that starting insulin within one year of diagnosis of diabetes may be associated with an increased risk of gallbladder disease.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Diabetes severity (requiring insulin early) can raise gallbladder risk; moderate usefulness for risk stratification.,TRUE,3,,,,,,,,,,,,,,,,,,,,,positive
29,Bipolar and major depression status_None,1,"The association between bipolar disorder and major depression with gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the literature. While both conditions are prevalent in the general population, the specific correlation between mood disorders and gallbladder diseases has not been extensively studied or established. The existing documents primarily focus on the pathophysiology and treatment of gallbladder diseases and do not provide substantial evidence linking these conditions with bipolar disorder or major depression. Therefore, this association can be considered novel as it may provide new insights into the interplay between psychiatric and gastrointestinal conditions, which is not commonly explored in current medical literature.",0,"To determine if there is a plausible explanation for the relationship between 'Bipolar and major depression status' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the known mechanisms and theories surrounding both conditions. Bipolar disorder and major depression are primarily psychiatric conditions characterized by mood disturbances, while cholelithiasis and related gallbladder diseases are physical conditions related to the digestive system. The linear correlation of 0.014 suggests a very weak positive relationship, indicating that as one condition changes, the other does not significantly change in a predictable manner. There is no established biological or psychological mechanism that directly links mood disorders with gallbladder diseases. While stress and lifestyle factors can influence both mental health and physical health, the specific connection between bipolar disorder and gallbladder diseases is not well-supported in the literature. Therefore, it is reasonable to conclude that there is no strong or plausible explanation for this relationship based on current understanding.",TRUE,3,"The feature 'Bipolar and major depression status' in relation to gallbladder diseases is interesting primarily due to its novelty. The association between psychiatric conditions like bipolar disorder and major depression with gallbladder diseases is not well-documented, which means this feature could potentially open new avenues for research into the interplay between mental health and gastrointestinal conditions. However, the plausibility of this association is weak. There are no known biological or psychological mechanisms directly linking mood disorders with gallbladder diseases, and the correlation is very weak (0.014), suggesting that any relationship is not strong or direct. While lifestyle factors influenced by mood disorders could theoretically impact physical health, the specific link to gallbladder diseases lacks strong support. Given these considerations, the feature is novel but not strongly plausible, making it moderately interesting to researchers who might be interested in exploring unconventional or under-researched areas.",0.014,0,0.004,0.034,1.02,Bipolar and major depression status_None >= 0.50,TRUE,"The feature 'Bipolar and major depression status' is not directly related to the target disease 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis'. The provided documents do not mention any correlation between bipolar and major depression status and the target disease. The risk factors mentioned in the documents include female gender, obesity, rapid weight loss, pregnancy, advanced age, Hispanic or Pima Indians, and others, but not bipolar and major depression status. Therefore, the association between the feature 'Bipolar and major depression status' and the target disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Mood disorder status has limited direct bearing on gallbladder disease, offering slight or indirect utility at best.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
44,Z90.7 - Acquired absence of genital organ(s),,,,,,,"The feature 'Z90.7 - Acquired absence of genital organ(s)' is interesting because it has a positive correlation with the target disease 'GALLSTONES, Cholelithiasis', which implies that individuals with acquired absence of genital organs may have a higher risk of developing gallstones. This association is plausible as both conditions are related to hormonal imbalances and genetic factors. For instance, hormonal fluctuations during pregnancy can lead to gallstone formation, and individuals with genital organ abnormalities might have underlying hormonal imbalances. This feature is novel as it highlights an unconventional risk factor for gallstones and warrants further investigation to understand the underlying mechanisms. Additionally, this association could have practical applications in clinical settings, such as identifying high-risk individuals for gallstone prevention and treatment strategies. Overall, this feature is interesting due to its novelty, plausibility, and potential utility in improving patient outcomes.",0.004,0.883,0.002,0.001,,,,,(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),0,No clear pathophysiologic link to gallbladder disease; not useful in gallbladder risk profiling.,FALSE,1,Absence (morphologic abnormality),C1689985,Absence (morphologic abnormality). ,0,0.377,0,0,Z90.7 - Acquired absence of genital organ(s),0.08,0.08,99,337,inf,2482,100459,7,0.638,0.055,0,1,positive
34,Other specified gastritis,1,"The relationship between 'Other specified gastritis' and biliary diseases such as cholelithiasis, gallbladder disease, cholecystitis, and cholangitis is not well-documented in the provided documents. While there is extensive information on gallbladder diseases and their complications, there is no direct mention of a correlation between gastritis and these biliary conditions. The existing literature primarily focuses on the pathophysiology, diagnosis, and treatment of gallbladder diseases without establishing a clear link to gastritis. Therefore, the assertion that there is a positive correlation between 'Other specified gastritis' and biliary diseases appears to be novel and not well-established in current knowledge. This suggests that further research may be needed to explore this potential association.",0,"To determine if there is a plausible explanation for the association between 'Other specified gastritis' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the underlying mechanisms of these conditions. Cholelithiasis and gallbladder diseases can lead to inflammation in the biliary tract, which may also affect the stomach and lead to gastritis. The presence of gallstones can cause obstruction and inflammation, potentially leading to a cascade of inflammatory responses that could extend to the gastric mucosa. Additionally, conditions like chronic cholecystitis may be associated with changes in bile composition and flow, which could influence gastric health. However, the linear correlation of 0.014 suggests a very weak relationship, indicating that while there may be some connection, it is not strong enough to establish a direct causal link. Therefore, while there are mechanisms that could explain a relationship, the weak correlation suggests that it may not be significant. Thus, the answer is nuanced, leaning towards the absence of a strong, plausible explanation for a direct association.",TRUE,3,"The feature 'Other specified gastritis' is evaluated for its novelty and plausibility in predicting gallbladder-related diseases. 

1. **Novelty:** The relationship between gastritis and gallbladder diseases is not well-documented, making this feature novel. There is no established literature directly linking these conditions, suggesting that this correlation could provide new insights or prompt further research. This novelty is enhanced by the lack of direct mention in existing studies, indicating that it is not a trivial or previously known association.

2. **Plausibility:** The plausibility of this association is weak. While there are potential mechanisms where inflammation in the biliary tract could affect the stomach, leading to gastritis, the correlation is very weak (0.014). This suggests that any biological or mechanistic link is not strong or direct. The mechanisms proposed, such as inflammatory cascades, are speculative and not strongly supported by current understanding.

3. **Usefulness:** The feature's lift of 2.35 under the specified split indicates some utility in predictive models, but the weak correlation limits its practical application in clinical settings. It could be useful for hypothesis generation or exploratory research but lacks immediate clinical utility.

Overall, while the feature is novel due to the lack of existing research linking these conditions, the weak plausibility and correlation reduce its overall interest level.",0.014,0,0.003,0,2.35,Other specified gastritis >= 7.10,TRUE,"The feature 'Other specified gastritis' is not directly related to the target disease 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis'. The provided documents do not mention any correlation between 'Other specified gastritis' and the target disease. The documents primarily focus on risk factors such as female gender, obesity, rapid weight loss, pregnancy, advanced age, Hispanic or Pima Indians, and gallstones, but do not mention gastritis as a risk factor for gallbladder disease or its complications. Therefore, the association between 'Other specified gastritis' and the target disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Non-specific GI inflammation connection is weak; only marginally useful for gallbladder risk considerations.,FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
19,Townsend deprivation index at recruitment,1,"The Townsend deprivation index is a measure of material deprivation that has been associated with various health outcomes, including chronic diseases. The documents reviewed indicate that socioeconomic factors, including deprivation, can influence the prevalence and complications of gallbladder diseases such as cholelithiasis and cholecystitis. Document [2] mentions that the prevalence of gallstone disease increases with age and body mass index, which are often correlated with socioeconomic status. Additionally, Document [4] discusses the rising mortality rates associated with biliary diseases, which may also be linked to socioeconomic factors. While the association between deprivation and gallbladder diseases is acknowledged, the specific correlation between the Townsend deprivation index and these diseases may not be extensively documented in the literature. Therefore, while the relationship exists, it may not be widely recognized or emphasized, suggesting that it could be considered novel or at least underexplored in current research. Thus, the feature does provide new insights into the understanding of gallbladder diseases in relation to socioeconomic deprivation.",1,"The Townsend deprivation index is a measure of material deprivation that incorporates factors such as unemployment, non-car ownership, non-home ownership, and household overcrowding. These factors can influence health outcomes, including the prevalence of diseases like cholelithiasis (gallstones) and other gallbladder diseases. Socioeconomic status is known to affect access to healthcare, dietary habits, and lifestyle choices, which can contribute to the development of gallbladder diseases. For instance, individuals in more deprived areas may have limited access to healthy foods, leading to diets high in fats and sugars, which are risk factors for gallstone formation. Additionally, socioeconomic deprivation can correlate with higher rates of obesity, another risk factor for gallbladder disease. Therefore, a positive correlation of 0.02, while weak, suggests that there may be some association between socioeconomic deprivation and gallbladder diseases, likely due to these underlying mechanisms. Thus, it makes sense to consider that there is a plausible explanation for this relationship.",TRUE,3,"The Townsend deprivation index is a well-established measure of socioeconomic status, which is known to influence various health outcomes. The association between socioeconomic deprivation and gallbladder diseases is plausible due to factors like diet and access to healthcare, which are affected by socioeconomic status. Although the specific relationship between the Townsend index and gallbladder diseases might not be extensively documented, the general link between socioeconomic factors and these diseases is acknowledged. Therefore, the feature is not highly novel but is somewhat underexplored in the context of gallbladder diseases. The plausibility of the association is strong, given the known impact of socioeconomic factors on health. However, the novelty is moderate since socioeconomic status is a common consideration in health research. Thus, while the feature is interesting, it doesn't provide groundbreaking insights but rather reinforces existing knowledge with a specific measure.",0.02,0,0.01,0.001,1.25,1.90 <= Townsend deprivation index at recruitment < 2.30,FALSE,"The Townsend deprivation index at recruitment is a measure of socioeconomic status, which is a known risk factor for various health conditions, including gallbladder disease. The index takes into account factors such as income, education, and employment status to provide a comprehensive picture of an individual's socioeconomic position. Research has shown that individuals from lower socioeconomic backgrounds are more likely to experience gallbladder disease, including cholelithiasis, gallstones, and cholecystitis. This is likely due to a combination of factors, including limited access to healthcare, poor diet, and higher levels of stress. Therefore, the association between the Townsend deprivation index at recruitment and the target disease is well known and explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Socioeconomic deprivation can correlate with obesity and healthcare access, making it moderately relevant to gallbladder disease.",TRUE,3,,,,,,,,,,,,,,,,,,,,,positive
32,Treatment/medication code | Array 0__omeprazole,1,"The association between omeprazole, a proton pump inhibitor, and gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis is not well-documented in the literature. While omeprazole is primarily used to treat conditions related to excess stomach acid, its effects on gallbladder function or gallstone formation are not widely recognized or established. Current knowledge primarily focuses on the role of dietary factors, obesity, and genetic predispositions in gallstone disease. Therefore, the mention of omeprazole in relation to these conditions could be considered novel or surprising, as it does not align with the established understanding of gallbladder disease etiology. This suggests that further investigation into this association may be warranted, indicating that it could provide new insights into the management or understanding of gallbladder diseases.",0,"Omeprazole is a proton pump inhibitor (PPI) primarily used to reduce stomach acid production. While it is not directly indicated for the treatment of gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis, there are some indirect mechanisms that could explain a potential association. For instance, PPIs like omeprazole can alter the gastrointestinal environment, potentially affecting bile composition and motility. This alteration might influence gallstone formation or the symptoms associated with gallbladder diseases. However, the linear correlation of 0.015 is very weak, suggesting that any relationship is likely not clinically significant. Therefore, while there could be a theoretical basis for a relationship, it is not strong enough to be considered plausible in a practical sense. Thus, the answer is B, as the weak correlation does not support a meaningful association between omeprazole and gallbladder diseases.",TRUE,3,"The feature 'medication omeprazole' in relation to gallbladder diseases presents an interesting case. From a novelty perspective, the association between omeprazole and gallbladder diseases is not well-documented, making it a novel finding. Omeprazole is primarily used to treat conditions related to excess stomach acid, and its effects on gallbladder function are not established in the literature. This suggests that the feature could provide new insights into the management or understanding of gallbladder diseases, warranting further investigation. Regarding plausibility, while there are some indirect mechanisms through which omeprazole could potentially influence gallbladder diseases (such as altering bile composition or gastrointestinal motility), these are speculative and not strongly supported by existing evidence. The weak correlation of 0.015 further suggests that any relationship is likely not clinically significant. Therefore, while the feature is novel, its plausibility is weak, and its practical utility is limited. Overall, the feature is somewhat interesting due to its novelty, but its weak plausibility and limited utility reduce its overall interest level.",0.015,0,0.004,0,1.44,Treatment/medication code | Array 0__omeprazole >= 0.50,TRUE,"The feature'medication omeprazole' is not directly related to the prediction of 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis'. Omeprazole is a medication used to treat gastroesophageal reflux disease (GERD) and other conditions, but it is not a known risk factor for gallbladder disease or cholelithiasis. The primary risk factors for gallbladder disease include female gender, obesity, rapid weight loss, and certain genetic and metabolic conditions. Omeprazole is not mentioned in any of the provided documents as a risk factor for gallbladder disease or cholelithiasis. Therefore, the association between'medication omeprazole' and the target disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"PPI usage is not strongly associated with gallbladder disease; correlation is weak, so limited utility.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
25,(AAM) age at menopause genetic risk,1,"The relationship between age at menopause (AAM) and gallbladder diseases such as cholelithiasis, gallstones, cholecystitis, and cholangitis is not extensively documented in the literature. While there are known risk factors for gallbladder disease, including female sex and hormonal influences, the specific genetic risk associated with AAM and its negative correlation with gallbladder diseases is less explored. The existing studies primarily focus on the general risk factors and hormonal influences rather than a direct genetic association with AAM. Therefore, the potential association of AAM genetic risk with gallbladder diseases could be considered novel, as it may provide new insights into the genetic underpinnings of gallbladder disease susceptibility, especially in the context of hormonal changes during menopause. This suggests that the feature could indeed contradict or expand upon established understanding, indicating a need for further research in this area.",0,"The question asks whether there is a plausible explanation for the association between age at menopause genetic risk (AAM) and gallbladder diseases such as cholelithiasis, gallstones, cholecystitis, and cholangitis. The linear correlation is negative (-0.005), suggesting that as the genetic risk for age at menopause increases, the incidence of gallbladder diseases may decrease slightly. This could be explained by the hormonal changes that occur during menopause, which can influence gallbladder function and bile composition. Estrogen, which decreases after menopause, has been shown to affect cholesterol metabolism and gallbladder motility. Therefore, the absence of estrogen post-menopause could lead to changes in gallbladder function that might reduce the risk of gallstone formation. However, the negative correlation is very weak, indicating that this relationship may not be strong or significant. Overall, while there are mechanisms that could explain a relationship, the weak correlation suggests that it may not be clinically relevant. Thus, the answer is nuanced, but given the context, it leans towards a lack of strong evidence for a significant association. Therefore, the most appropriate choice is B. No, there is no plausible explanation for this relationship.",TRUE,3,"The feature '(AAM) age at menopause genetic risk' is evaluated for its association with gallbladder diseases. In terms of novelty, the relationship between genetic risk for age at menopause and gallbladder diseases is not well-documented, making it potentially novel. Most existing literature focuses on hormonal influences rather than direct genetic links, suggesting that this feature could provide new insights into the genetic aspects of gallbladder disease risk. Regarding plausibility, while hormonal changes post-menopause can affect gallbladder function, the negative correlation is weak (-0.005), suggesting that any potential biological mechanism is not strong or clear. The weak correlation and lack of strong biological explanation make the association less plausible. However, the novelty of exploring genetic links to menopause and gallbladder diseases could still be of interest to researchers. Overall, while the feature is not highly plausible, its novelty in exploring genetic underpinnings makes it somewhat interesting for further research, although its practical utility remains limited due to the weak correlation.",-0.005,0.004,0.007,0,1.32,0.68 <= (AAM) age at menopause genetic risk < 0.69,TRUE,"The association between the feature '(AAM) age at menopause genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not explicitly mentioned in the provided documents. However, the documents do mention that female gender is a risk factor for gallstone formation, and that women are more likely to develop gallstones than men. Additionally, the documents mention that estrogen levels have been shown to correlate with bile cholesterol and a decrease in gallbladder contractility, which may contribute to the increased risk of gallstone formation in women. Therefore, while the specific association between age at menopause genetic risk and gallstone disease is not explicitly mentioned, it is plausible that genetic factors related to age at menopause could influence the risk of gallstone formation, given the established link between female gender and gallstone disease.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Hormonal influences do matter, but negative correlation is weak; slight potential utility only.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
50,M79.66 - Pain in limb (Lower leg),,,,,,,"The feature 'M79.66 - Pain in limb (Lower leg)' is interesting because it suggests a potential correlation between pain in the lower leg and the risk of developing gallstones (Cholelithiasis). This association is plausible as both conditions are related to gastrointestinal issues and could be influenced by similar factors such as diet, lifestyle, or underlying health conditions. The novelty of this feature lies in its potential to identify patients at risk of gallstones through a non-invasive symptom-based approach, which could be useful in early detection and prevention strategies.",0.001,0.819,0,0,,,,,(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),0,No direct or recognized link to gallbladder pathology; no practical predictive value.,FALSE,1,Administration Method - Pain,C1549543,Administration Method - Pain. ,0,0.194,1,0.2,M79.66 - Pain in limb (Lower leg),-0.03,-0.03,99,106,inf,119917,100459,587,1,0.85,0,2,positive
33,Acetone,1,"The association between 'Acetone' and conditions such as 'Cholelithiasis', 'Gallstone', 'Gallbladder disease', 'Cholecystitis', or 'Cholangitis' is not well-documented in current medical literature. Acetone is primarily known as a ketone body produced during fat metabolism, and its relationship with gallbladder diseases is not established. The negative correlation mentioned suggests that higher levels of acetone may be associated with a lower incidence of these diseases, which contradicts the common understanding that gallbladder diseases are often linked to metabolic factors, including obesity and dyslipidemia. Therefore, this association could be considered novel as it challenges existing paradigms regarding the metabolic factors influencing gallbladder health. Thus, it provides new insights into the potential metabolic interactions that could influence gallbladder disease risk.",0,"Acetone is a ketone body that is produced during the metabolism of fats, particularly in states of fasting, low carbohydrate intake, or uncontrolled diabetes. It is not directly related to the pathophysiology of gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis. These conditions are primarily associated with the presence of gallstones, inflammation, and obstruction of the biliary tract, which are influenced by factors such as diet, obesity, and genetics rather than ketone metabolism. The negative correlation of -0.011 suggests that as acetone levels increase, the incidence of these gallbladder diseases does not increase, which aligns with the understanding that acetone does not play a role in the mechanisms leading to these diseases. Therefore, there is no plausible explanation for a relationship between acetone and gallbladder diseases based on known mechanisms or theories.",TRUE,3,"The feature 'Acetone' is evaluated for its relationship with gallbladder diseases, which is not well-documented in existing literature. Acetone is primarily known as a metabolic byproduct during states of ketosis, such as fasting or low carbohydrate intake. The negative correlation between acetone levels and gallbladder diseases is intriguing because it suggests a protective effect, which contradicts the common understanding that metabolic syndrome factors like obesity increase gallbladder disease risk. This makes the finding novel, as it challenges established paradigms regarding metabolic influences on gallbladder health. However, the plausibility of this association is low because there are no known biological mechanisms linking acetone directly to gallbladder disease prevention. Gallbladder diseases are typically associated with factors like cholesterol metabolism and bile composition, rather than ketone body levels. Therefore, while the feature is novel, its lack of plausible biological explanation limits its overall interest. Given these considerations, the feature is somewhat interesting due to its novelty but not highly plausible or useful without further investigation.",-0.011,0,0.004,0,1.91,#NAME?,TRUE,"The relationship between acetone and gallbladder disease is not directly related. Acetone is a solvent used in various applications, including medical procedures, but it is not a known risk factor for gallbladder disease. The formation of gallstones and gallbladder disease is influenced by factors such as genetic predisposition, diet, obesity, and metabolic disorders, but acetone is not a known contributor to these conditions. Therefore, the association between acetone and gallbladder disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Reflects certain metabolic states (ketosis), but not strongly tied to gallbladder disease for clinical application.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
47,Ever addicted to a behaviour or miscellanous_Yes,,,,,,,"The feature 'Ever addicted to a behaviour or miscellanous_Yes' is interesting because it suggests an association between past addictive behaviors and the risk of developing gallstones, a condition where solid particles form in the gallbladder. This is plausible as addiction can lead to unhealthy lifestyle choices, including poor diet and lack of exercise, which may contribute to gallstone formation. Additionally, this feature's novelty lies in its exploration of a non-traditional risk factor for gallstones, which can help identify new avenues for prevention and early intervention.",-0.001,0.672,0,0,,,,,(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),0,Behavioral addiction lacks clear association with gallbladder disease risk; no actionable utility.,FALSE,1,addict,C0858354,addict. ,0,0.655,0,0,Ever addicted to a behaviour or miscellanous_Yes,0.08,0.08,2,116,0.21,155393,100459,41,0,-3.363,0,1,negative
18,Time spend outdoors in summer_2,1,"The relationship between time spent outdoors and various health conditions, including gallbladder diseases such as cholelithiasis and cholecystitis, is not extensively documented in the literature. While there are known risk factors for gallbladder diseases, such as obesity and diet, the specific impact of outdoor time on these conditions is less clear. The negative correlation observed between time spent outdoors in summer and gallbladder diseases could suggest that increased outdoor activity may be associated with lower incidence or severity of these conditions, potentially due to lifestyle factors such as increased physical activity or improved dietary habits. However, this relationship is not widely recognized or established in current medical literature, making it a novel observation. Therefore, it provides new insights into the potential influence of lifestyle factors on gallbladder health.",1,"The question asks whether there is a plausible explanation for a negative correlation between time spent outdoors in summer and various gallbladder diseases, including cholelithiasis, cholecystitis, and cholangitis. A negative correlation of -0.009 suggests that as time spent outdoors increases, the incidence of these diseases does not increase, which could imply that outdoor activity does not contribute to the development of these conditions. One possible explanation could be that individuals who spend more time outdoors may engage in healthier lifestyles, such as increased physical activity and better dietary choices, which could reduce the risk of gallbladder diseases. Additionally, exposure to sunlight and outdoor environments may have positive effects on overall health, potentially influencing factors like obesity and metabolic health, which are related to gallbladder disease. Therefore, it is reasonable to conclude that there is a plausible explanation for this relationship, as outdoor activity may be associated with healthier lifestyle choices that mitigate the risk of gallbladder diseases.",TRUE,3,"1. **Novelty:** The feature 'Time spend outdoors in summer' is not a well-documented risk factor for gallbladder diseases such as cholelithiasis or cholecystitis. The existing literature primarily focuses on factors like obesity, diet, and genetics. The observation of a negative correlation between outdoor time and gallbladder diseases is novel because it suggests a potential lifestyle factor that has not been extensively explored in relation to these diseases.

2. **Plausibility:** The plausibility of this feature stems from the potential indirect effects of spending time outdoors. Increased outdoor activity could lead to more physical exercise and healthier lifestyle choices, which are known to reduce the risk of obesity—a significant risk factor for gallbladder diseases. Additionally, sunlight exposure could influence vitamin D levels, which have been implicated in various metabolic processes. However, the direct biological mechanisms linking outdoor time specifically to reduced gallbladder disease risk are not well-established, making this correlation somewhat speculative.

3. **Usefulness:** While the feature is novel and somewhat plausible, its practical utility is limited unless further research establishes a stronger causal link. It could inspire new studies into lifestyle interventions for gallbladder disease prevention, but its immediate application in clinical settings is minimal.

Overall, the feature is interesting due to its novelty and potential implications for lifestyle-related research on gallbladder diseases, but it requires more evidence to be considered highly impactful.",-0.009,0,0.003,0.003,1.01,Time spend outdoors in summer_2 < 0.50,TRUE,"The feature 'Time spend outdoors in summer' is not directly related to the development of cholelithiasis, gallstone, gallbladder disease, cholecystitis, or cholangitis. The known risk factors for these conditions include female gender, obesity, rapid weight loss, pregnancy, advanced age, Hispanic or Pima Indian ethnicity, and genetic predisposition. There is no established link between time spent outdoors in summer and the development of these conditions. Therefore, the association between this feature and the target disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Might link to healthier habits, but correlation is too weak to yield concrete clinical utility.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
7,Acetate,1,"The feature 'Acetate' is not commonly associated with gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis in the existing literature. Most studies focus on factors like cholesterol levels, obesity, and dietary fats as contributors to gallstone formation and gallbladder disease. If 'Acetate' has a negative correlation with these diseases, it suggests that higher levels of acetate might be protective or inversely related to the risk of developing these conditions. This could be considered a novel finding, as it contradicts the established understanding that focuses on other dietary components. Therefore, this association could provide new insights into the dietary factors influencing gallbladder health and disease risk, making it a novel observation.",1,"The question asks whether there is a plausible explanation for the negative correlation between 'Acetate' and diseases such as Cholelithiasis, Gallstone, Gallbladder disease, Cholecystitis, or Cholangitis. Acetate is a short-chain fatty acid that can be produced during the fermentation of dietary fibers in the gut. While acetate itself is not directly linked to gallbladder diseases, it may influence bile acid metabolism and gut health. However, a negative correlation suggests that higher levels of acetate might be associated with lower incidences of these diseases, which could be due to acetate's role in promoting gut health and potentially reducing inflammation. This could imply that acetate has a protective effect against the development of gallbladder diseases. Therefore, there is a plausible explanation for this relationship, as acetate may contribute to a healthier gut environment that could mitigate the risk of gallstone formation and related diseases.",TRUE,4,"The feature 'Acetate' is not typically associated with gallbladder diseases in existing literature, which primarily focuses on cholesterol, obesity, and dietary fats. The negative correlation suggests that higher acetate levels might be protective against these diseases, which is a novel finding. This novelty is significant as it challenges the traditional understanding and introduces a new potential protective factor. From a plausibility standpoint, acetate is a short-chain fatty acid produced by gut fermentation of dietary fibers. It is known to influence gut health and potentially reduce inflammation, which could plausibly contribute to a lower risk of gallbladder diseases. This plausible mechanism adds credibility to the association, making it not only novel but also scientifically interesting. Thus, the feature 'Acetate' is both novel and plausible, making it an interesting subject for further research.",-0.011,0.242,0.003,0,2.21,#NAME?,TRUE,"The feature 'Acetate' is not directly related to the prediction of the target disease 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis'. The provided documents do not mention 'Acetate' as a risk factor or protective factor for any of the mentioned diseases. The documents discuss various risk factors such as obesity, metabolic syndrome, genetic factors, and others, but 'Acetate' is not among them. Therefore, the association between 'Acetate' and the target disease is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"A short-chain fatty acid with possible metabolic influences, but no strong evidence for gallbladder disease management.",FALSE,2,,,,,,,,,,,,,,,,,,,,,negative
46,"Epilepsy, recurrent seizures, convulsions",,,,,,,"The feature 'Epilepsy, recurrent seizures, convulsions' is interesting because it has a positive correlation with the target disease 'GALLSTONES, Cholelithiasis'. This association is plausible as epilepsy, recurrent seizures, and convulsions can be indicative of underlying neurological or metabolic issues that may also contribute to the development of gallstones. The feature is novel as it explores an unconventional association that may not be well-documented in existing literature. This correlation could have practical applications, such as informing clinical interventions or tests to detect individuals at higher risk of developing gallstones.",0.001,0.873,0,0,,,,,(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),0,No known mechanism or clinical reason to connect seizure disorders with gallbladder disease.,FALSE,1,Acute repetitive seizure,C3203523,"Acute repetitive seizure. A fourfold or greater increase of usual seizure frequency within a 3-day period, where the patient demonstrates full recovery between seizure events within the cluster. The seizure cluster should be recognisable by the primary clinician, carer or patient. [PMID:29871784, PMID:32305858]",0,0.604,0,0,"Epilepsy, recurrent seizures, convulsions",0.12,0.12,2,3,0.08,386,100459,0,0.35,0,0,0,positive
49,Behavioural and miscellaneous addictions_Something else not mentioned,,,,,,,"The feature 'Behavioural and miscellaneous addictions_Something else not mentioned' is interesting as it suggests a novel association between non-substance-related addictions and the risk of developing gallstones. This relationship is plausible as both are linked to stress, anxiety, and unhealthy lifestyle choices. The feature's novelty lies in its exploration of the lesser-studied area of non-substance addictions, which could have potential practical applications in identifying high-risk patients and informing preventive measures.",0.001,0.673,0,0,,,,,(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),0,No recognized relationship to gallbladder disease; no clear utility.,FALSE,1,Addictive Behavior,C0085281,"Addictive Behavior. The observable, measurable, and often pathological activity of an organism that portrays its inability to overcome a habit resulting in an insatiable craving for a substance or for performing certain acts. The addictive behavior includes the emotional and physical overdependence on the object of habit in increasing amount or frequency.",0,0.713,0,0,Behavioural and miscellaneous addictions_Something else not mentioned,0.14,0.21,2,75,0.08,19096,100459,1,0,-5.696,0,0,positive
42,(ISS) ischaemic stroke genetic risk,1,"The relationship between ischaemic stroke genetic risk and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the provided literature. While there are established risk factors for both conditions, the specific genetic associations linking ischaemic stroke to gallbladder diseases have not been extensively explored or reported. Therefore, the potential correlation could be considered novel, as it may provide new insights into the interplay between genetic predispositions for stroke and gallbladder-related conditions. This suggests that further research could uncover significant connections that are currently not recognized in the existing literature.",1,"To determine if there is a plausible explanation for the association between ischaemic stroke genetic risk and gallbladder diseases (including cholelithiasis, gallstones, cholecystitis, and cholangitis), we need to consider the underlying mechanisms of both conditions. Ischaemic stroke is often linked to vascular health, and risk factors such as obesity, diabetes, and metabolic syndrome can contribute to both ischaemic stroke and gallbladder diseases. For instance, obesity is a known risk factor for gallstone formation and ischaemic stroke. Additionally, chronic inflammation, which can be present in gallbladder diseases, may also play a role in vascular health and stroke risk. The positive linear correlation of 0.011 suggests a very weak association, but it does indicate that there may be some shared risk factors or underlying mechanisms that connect these conditions. Therefore, it is reasonable to conclude that there is a plausible explanation for this relationship, albeit weak. Thus, the answer is A.",FALSE,3,"The feature 'ischaemic stroke genetic risk' (ISS) being correlated with gallbladder diseases is intriguing due to its novelty. There is limited existing literature exploring the genetic links between stroke and gallbladder conditions, making this association potentially novel. This could open new research avenues into shared genetic pathways or risk factors. However, the plausibility of this association is weak. The known risk factors for both conditions, such as obesity and metabolic syndrome, might explain the correlation without needing a direct genetic link. The shared risk factors could lead to a spurious correlation, rather than a direct genetic association. The feature's utility is questionable, as the correlation is very weak (0.011), suggesting limited practical application in clinical settings. Overall, while the novelty is present, the weak plausibility and utility reduce the overall interest of this feature.",0.011,0,0.007,0,1.8,0.49 <= (ISS) ischaemic stroke genetic risk < 0.49,TRUE,"The relationship between ischaemic stroke genetic risk and gallbladder disease is not directly related. Ischaemic stroke is a condition that occurs when the blood supply to the brain is interrupted or reduced, causing damage to the brain tissue. Gallbladder disease, on the other hand, is a condition that affects the gallbladder, a small organ located under the liver that stores bile. The two conditions are not directly related, and there is no established link between ischaemic stroke genetic risk and the development of gallbladder disease. The risk factors for gallbladder disease include obesity, female gender, rapid weight loss, pregnancy, advanced age, and Hispanic or Pima Indian ethnicity, but not ischaemic stroke genetic risk.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Shares some metabolic risk factors with gallbladder disease, but correlation is weak; limited clinical usefulness.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
31,(POAG) primary open angle glaucoma genetic risk,1,"The association between primary open-angle glaucoma (POAG) genetic risk and gallbladder diseases such as cholelithiasis, gallstones, cholecystitis, or cholangitis is not well-documented in the current literature. While both conditions have genetic components, the specific relationship between POAG genetic risk factors and gallbladder diseases has not been established or widely recognized. The negative correlation mentioned suggests that higher genetic risk for POAG may be associated with a lower incidence of gallbladder diseases, which is counterintuitive and not supported by existing research. Therefore, this association can be considered novel as it provides new insights that contradict established understanding of the independent nature of these diseases. Thus, the answer is A.",0,"To determine if there is a plausible explanation for the association between 'POAG primary open angle glaucoma genetic risk' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis', we need to consider the underlying mechanisms of both conditions. Primary open-angle glaucoma (POAG) is primarily an optic neuropathy associated with genetic factors, particularly those affecting intraocular pressure and optic nerve health. On the other hand, cholelithiasis and related gallbladder diseases are primarily metabolic and involve the formation of gallstones due to imbalances in bile components, often influenced by dietary factors, obesity, and other metabolic syndromes. The negative linear correlation of -0.003 suggests that as the genetic risk for POAG increases, the risk for gallbladder diseases does not increase, indicating no direct relationship. Given the distinct pathophysiological mechanisms and risk factors for these two conditions, there is no known biological or clinical rationale to suggest a plausible link between them. Therefore, the conclusion is that there is no plausible explanation for this relationship.",TRUE,3,"The feature 'POAG primary open angle glaucoma genetic risk' is being evaluated for its association with gallbladder diseases. In terms of novelty, this association is indeed novel because there is no established literature or known biological pathway linking glaucoma genetic risks with gallbladder diseases. The negative correlation observed is counterintuitive, as these conditions are generally considered independent, with glaucoma being primarily an optic nerve condition and gallbladder diseases being metabolic. This unexpected finding could suggest a new area of research, although it might also be a spurious correlation. In terms of plausibility, there is no known biological mechanism that would logically connect these two conditions. The distinct pathophysiological mechanisms of POAG and gallbladder diseases make a direct link unlikely. Therefore, while the feature is novel, it lacks plausibility, which diminishes its overall interest. However, the novelty alone might still intrigue researchers to explore potential unknown pathways or confounding factors. Given these considerations, the feature is somewhat interesting due to its novelty but not strongly compelling due to the lack of plausible explanation.",-0.003,0.043,0.004,0,1.33,#NAME?,TRUE,"The relationship between POAG primary open angle glaucoma genetic risk and Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis is not directly related. POAG is a condition affecting the eye, while Cholelithiasis, Gallstone, Gallbladder disease, cholecystitis, and Cholangitis are related to the gallbladder and biliary system. There is no known direct correlation between the genetic risk factors of POAG and the development of gallbladder diseases. The risk factors for gallbladder diseases are more related to metabolic, environmental, and genetic factors such as obesity, diabetes, and gallstone formation, rather than eye-related conditions like POAG.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Distinct pathophysiology, offering no relevant insight for gallbladder disease risk.",FALSE,1,,,,,,,,,,,,,,,,,,,,,negative
48,Behavioural and miscellaneous addictions_A behaviour,,,,,,,"The feature 'Behavioural and miscellaneous addictions_A behaviour' is interesting because it has a neutral correlation with the target disease 'GALLSTONES, Cholelithiasis'. This feature is interesting because it provides new insights into the potential link between behavioral addictions and gallstones. The novelty of this feature lies in its ability to explore a previously unexamined association between two seemingly unrelated conditions. This association is plausible because both behavioral addictions and gallstones have been linked to stress, which is a known risk factor for gallstone formation. The usefulness of this feature lies in its potential to inform clinical interventions or tests that target the underlying mechanisms of both conditions. For instance, addressing behavioral addictions through therapy may have a positive impact on reducing stress and subsequently lowering the risk of gallstone formation. This feature is also interesting because it highlights the importance of considering the interplay between lifestyle factors and medical conditions, which can lead to new avenues for research and treatment.",0,0.921,0,0,,,,,(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),0,Lacks specific linkage to gallbladder disease; not useful in risk or management.,FALSE,1,Addictive Behavior,C0085281,"Addictive Behavior. The observable, measurable, and often pathological activity of an organism that portrays its inability to overcome a habit resulting in an insatiable craving for a substance or for performing certain acts. The addictive behavior includes the emotional and physical overdependence on the object of habit in increasing amount or frequency.",0,0.761,0,0,Behavioural and miscellaneous addictions_A behaviour,0.07,0.09,2,75,0.08,19096,100459,1,0,-5.696,0,0,neutral
16,Fed-up feelings_Yes,1,"The feature 'Fed up feelings' is not a commonly documented symptom or characteristic directly associated with cholelithiasis, gallstone disease, cholecystitis, or cholangitis in the existing literature. While emotional states can be influenced by chronic pain or discomfort associated with these conditions, the specific term 'Fed up feelings' does not appear in the medical documents reviewed. Therefore, this association could be considered novel as it does not contradict established understanding but rather suggests a potential emotional or psychological aspect that has not been widely recognized in the context of these physical diseases. Thus, it may provide new insights into the patient experience related to these conditions.",1,"The feature 'Fed up feelings' may relate to the emotional and psychological impact of chronic pain or discomfort associated with gallbladder diseases such as cholelithiasis, cholecystitis, or cholangitis. Patients suffering from these conditions often experience significant abdominal pain, nausea, and other gastrointestinal symptoms, which can lead to feelings of frustration, helplessness, or being fed up with their condition. The positive linear correlation of 0.03 suggests a slight association, indicating that as the severity or frequency of gallbladder-related symptoms increases, patients may also report higher levels of fed-up feelings. This emotional response can be understood as a common psychological reaction to chronic health issues, making it plausible to associate 'Fed up feelings' with these diseases. Therefore, there is a reasonable mechanism that explains this relationship.",TRUE,3,"The feature 'Fed up feelings' is evaluated based on its novelty, plausibility, and potential utility. 

1. **Novelty:** The concept of 'Fed up feelings' as a predictor for gallbladder-related diseases is novel because it is not a commonly documented symptom or risk factor in medical literature. Emotional states are generally not directly linked to the pathophysiology of gallbladder diseases, which are typically associated with physical symptoms like abdominal pain, nausea, and digestive issues. Therefore, the introduction of an emotional or psychological aspect is new and could provide additional insights into patient experiences that have not been widely explored.

2. **Plausibility:** The plausibility of this feature is moderate. While it is reasonable to assume that chronic pain and discomfort from gallbladder diseases could lead to emotional distress, the specific term 'Fed up feelings' is vague and not clinically defined. However, the emotional response to chronic illness is a well-documented phenomenon, and it is plausible that patients with persistent symptoms might feel frustrated or fed up. The slight positive correlation suggests a potential link, but it is not strong enough to establish a direct causal relationship.

3. **Usefulness/Utility:** The practical application of this feature is limited. While it might offer some insight into the psychological burden of gallbladder diseases, it is unlikely to directly influence clinical interventions or diagnostic criteria. It could, however, be useful in holistic patient care approaches that consider mental health alongside physical symptoms.

Overall, the feature is interesting due to its novelty and the potential to explore the emotional dimensions of chronic gallbladder diseases, but its clinical utility remains questionable.",0.03,0,0.006,0.019,1.11,Fed-up feelings_Yes >= 0.50,TRUE,"The feature 'Fed-up feelings_Yes' is not explicitly mentioned in the provided documents as a risk factor or a known association with the target diseases. The documents primarily focus on the risk factors for cholelithiasis, gallstone, gallbladder disease, cholecystitis, and cholangitis, including female gender, obesity, rapid weight loss, pregnancy, advanced age, and genetic predisposition. While the documents discuss the importance of patient education and risk factor modification, 'Fed-up feelings' is not explicitly linked to these conditions. Therefore, the association between 'Fed-up feelings' and the target diseases is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Psychological distress is non-specific; while it can co-occur with chronic illness, it offers little direct predictive utility.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
9,(RA) rheumatoid arthritis genetic risk,1,"The association between rheumatoid arthritis (RA) genetic risk and gallbladder diseases such as cholelithiasis or cholecystitis is not well-documented in the current literature. While RA is known to have various systemic effects and can lead to complications, the specific link between RA genetic risk factors and gallbladder diseases has not been established as a common or recognized correlation. The existing documents primarily discuss RA's impact on joints and other systemic conditions but do not provide substantial evidence or insights into gallbladder disease. Therefore, this association can be considered novel as it does not contradict established understanding but rather highlights a potential area for further research.",1,"Rheumatoid arthritis (RA) is an autoimmune disease that can lead to systemic inflammation, which may affect various organs, including the gallbladder. The presence of gallbladder disease, such as cholecystitis, has been reported in patients with RA, particularly those with severe disease or complications. The inflammation associated with RA could potentially contribute to gallbladder dysfunction or disease. Additionally, the chronic inflammation seen in RA may influence gallbladder motility and bile composition, leading to conditions like cholelithiasis (gallstones). However, the linear correlation of 0.005 suggests a very weak relationship, indicating that while there may be some association, it is not strong enough to definitively establish a causal link. Therefore, while there are mechanisms that could explain a relationship between RA and gallbladder disease, the weak correlation raises questions about the strength of this association. Overall, it is reasonable to suggest that there is a plausible explanation for the relationship, but the evidence is not robust enough to confirm it definitively.",TRUE,4,"The feature 'RA genetic risk' in relation to gallbladder diseases is intriguing due to its novelty. The association is not well-documented in existing literature, which primarily focuses on RA's impact on joints and systemic inflammation rather than specific links to gallbladder conditions. This makes the feature novel as it suggests a potential area for further research that has not been extensively explored. In terms of plausibility, RA is an autoimmune condition that causes systemic inflammation, which could theoretically affect the gallbladder. Chronic inflammation might alter bile composition or gallbladder motility, potentially leading to gallstones or cholecystitis. However, the very weak correlation (0.005) indicates that while a plausible mechanism exists, the strength of the association is minimal, suggesting that any link is likely indirect or influenced by other factors. Despite the weak correlation, the novelty of the association and the potential for uncovering new pathways or risk factors make the feature interesting to researchers. Therefore, it is worth investigating further, especially in understanding systemic effects of autoimmune diseases like RA.",0.005,0.002,0.004,0,1.56,(RA) rheumatoid arthritis genetic risk < -2.80,FALSE,"The relationship between rheumatoid arthritis genetic risk and cholelithiasis, gallstone, gallbladder disease, cholecystitis, and cholangitis is not directly established. However, there are some connections between the two. For instance, rheumatoid arthritis is associated with an increased risk of gallstones, which can lead to cholelithiasis, gallbladder disease, cholecystitis, and cholangitis. The shared epitope in HLA-DRB1 is a genetic risk factor for rheumatoid arthritis and has been linked to an increased risk of gallstones. Additionally, the presence of anti-citrullinated protein antibodies (anti-CCP) in rheumatoid arthritis patients has been associated with an increased risk of gallstones. Furthermore, the altered gut microbiome in rheumatoid arthritis patients has been linked to an increased risk of gallstones. Therefore, while the relationship is not direct, there are some connections and associations between rheumatoid arthritis genetic risk and the development of cholelithiasis, gallstone, gallbladder disease, cholecystitis, and cholangitis.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Systemic inflammation might tangentially affect gallbladder, but correlation is weak; slight potential utility only.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
11,Concentration of Very Large HDL Particles,1,"The relationship between high-density lipoprotein (HDL) particles, particularly very large HDL particles, and various diseases, including gallbladder diseases such as cholelithiasis and cholecystitis, is an area of ongoing research. Current literature suggests that higher concentrations of HDL, especially large HDL particles, are generally associated with better cardiovascular health and lower risks of atherosclerosis. However, the specific association between very large HDL particles and gallbladder diseases is not extensively documented in the provided documents. While it is established that HDL plays a protective role in cardiovascular health, the direct correlation with gallbladder diseases is less clear and may not be well understood. Therefore, if there is a negative correlation between the concentration of very large HDL particles and gallbladder diseases, it could be considered novel or provide new insights, as this specific relationship is not widely discussed in the existing literature. Thus, the conclusion is that this association is likely novel or provides new insights.",1,"To determine if there is a plausible explanation for the negative correlation between the concentration of very large HDL particles and gallbladder diseases (such as cholelithiasis, gallstones, cholecystitis, and cholangitis), we need to consider the roles of HDL particles in cholesterol metabolism and gallbladder function. HDL particles are known to transport cholesterol back to the liver for excretion, which is beneficial for cardiovascular health. However, gallbladder diseases often involve cholesterol metabolism as well, particularly in the formation of gallstones, which are primarily composed of cholesterol. A higher concentration of very large HDL particles could theoretically indicate a more effective reverse cholesterol transport mechanism, potentially reducing the amount of free cholesterol available for gallstone formation. Therefore, a negative correlation might suggest that as the concentration of very large HDL particles increases, the risk of gallbladder disease decreases, which aligns with the known protective role of HDL in cholesterol management. Thus, there is a plausible explanation for this relationship, as higher concentrations of HDL could be associated with lower cholesterol levels in the bile, reducing the risk of gallstone formation. Hence, the answer is A.",TRUE,4,"The feature 'Concentration of Very Large HDL Particles' is evaluated for its association with gallbladder diseases. From a novelty perspective, the relationship between HDL particles and gallbladder diseases is not extensively documented, especially concerning very large HDL particles. Most existing research focuses on HDL's role in cardiovascular health, making this association relatively novel as it explores a less understood area. Regarding plausibility, HDL particles are involved in reverse cholesterol transport, which could theoretically reduce cholesterol available for gallstone formation. This provides a plausible biological mechanism for the negative correlation observed. Given these points, the feature is interesting as it opens new avenues for understanding the role of lipid metabolism in gallbladder diseases, which could have implications for future research and clinical practice.",-0.017,0,0.001,0.001,1.69,#NAME?,FALSE,"The Concentration of Very Large HDL Particles is related to the HDL cholesterol levels and its subfractions. HDL is known to have a protective effect against cardiovascular diseases. However, the relationship between HDL and gallstone formation is not directly related to the Concentration of Very Large HDL Particles. The formation of gallstones is more related to the supersaturation of bile with cholesterol, nucleation of cholesterol monohydrate, and abnormal gallbladder motor function. The Concentration of Very Large HDL Particles is not a known risk factor for gallstone formation. It is more related to cardiovascular health rather than gallstone disease.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Higher HDL could reduce cholesterol gallstones; moderately useful lipid marker for gallbladder risk profiling.,TRUE,3,,,,,,,,,,,,,,,,,,,,,negative
43,Degeneration of intervertebral disc,,,,,,,"The feature 'Degeneration of intervertebral disc' is interesting because it provides new insights into the association between spinal health and gallstone formation. This association is plausible, as both conditions are related to metabolic and inflammatory processes. The degeneration of intervertebral discs can lead to increased pressure on the abdominal organs, potentially influencing bile flow and stone formation. This feature has utility in understanding the risk factors for gallstones and may inform clinical interventions or tests to prevent or manage the condition.",0.003,0.984,0,0,,,,,(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),0,No connection to gallbladder disease risk; provides no clinically relevant information.,FALSE,1,Abnormal degeneration,C0011164,Abnormal degeneration. ,0,0.536,0,0,Degeneration of intervertebral disc,0.15,0.3,2,16,0,24143,100459,59,0.23,-0.152,0,1,positive
27,Neuroticism score,1,"The association between neuroticism and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not well-documented in the provided biomedical literature. While there is a significant amount of research on gallbladder diseases and their risk factors, the specific correlation with neuroticism scores is not mentioned. Therefore, this suggests that the relationship may not be widely recognized or established in current medical understanding. Given that the question posits a positive correlation and asks if this is novel or provides new insights, it indicates that this connection has not been previously highlighted in the literature. Thus, it can be concluded that this association is indeed novel and may provide new insights into the psychosomatic aspects of gallbladder diseases.",0,"The relationship between neuroticism and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis can be explored through several mechanisms. Neuroticism is often associated with increased stress and anxiety, which can lead to various physiological changes in the body, including alterations in digestion and metabolism. Stress can influence the gastrointestinal system, potentially leading to conditions like gallstones due to changes in bile composition and motility. Additionally, individuals with high neuroticism may engage in unhealthy lifestyle choices, such as poor diet and lack of exercise, which are known risk factors for gallbladder disease. However, the linear correlation of 0.019 is very weak, suggesting that while there may be some association, it is not strong enough to establish a clear causal link. Therefore, while there are mechanisms that could explain a relationship, the weak correlation indicates that it may not be significant. Thus, the answer is nuanced, leaning towards the absence of a strong plausible explanation for the relationship based on the weak correlation observed.",TRUE,3,"1. **Novelty:** The association between neuroticism and gallbladder diseases is not well-documented in existing literature, making it a novel area of investigation. This suggests that exploring this relationship could provide new insights into the psychosomatic aspects of gallbladder diseases, which are not traditionally linked to psychological traits like neuroticism.

2. **Plausibility:** While neuroticism is associated with stress and anxiety, which can affect physiological processes, the specific link to gallbladder diseases is not strongly supported by existing biological or physiological mechanisms. The weak correlation (0.019) suggests that any relationship is likely to be indirect or confounded by other factors, such as lifestyle choices influenced by neuroticism.

3. **Usefulness:** The practical utility of this feature is limited due to the weak correlation. It may not be strong enough to inform clinical interventions or significantly improve predictive models for gallbladder diseases. However, it could inspire further research into the psychosomatic factors influencing these conditions.

Overall, the feature is interesting due to its novelty, but the weak correlation and lack of strong plausible mechanisms limit its immediate utility. It could be a starting point for further research rather than a definitive predictor.",0.019,0,0.006,0.002,1.18,Neuroticism score >= 1.80,TRUE,"The provided documents do not mention any association between 'Neuroticism score' and the target diseases. The documents primarily focus on risk factors such as cholelithiasis, gallstones, obesity, female gender, age, and other medical conditions. There is no mention of 'Neuroticism score' as a risk factor for gallbladder disease or its complications. Therefore, the association between 'Neuroticism score' and the target diseases is not well known or explained by existing knowledge.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Weak psychological correlate, not robustly predictive or clinically actionable for gallbladder disease.",FALSE,2,,,,,,,,,,,,,,,,,,,,,positive
10,Concentration of Very Large VLDL Particles,1,"The relationship between very large VLDL particles and gallbladder diseases such as cholelithiasis, cholecystitis, and cholangitis is not explicitly documented in the provided documents. While there is extensive information on the metabolism of VLDL and its role in cardiovascular diseases, the specific association with gallbladder diseases is less clear. The documents primarily focus on gallbladder diseases being related to gallstones and inflammation, without direct mention of VLDL particle concentrations. Therefore, the potential correlation between very large VLDL particles and gallbladder diseases could be considered novel, as it has not been established in the current literature. This suggests that further research could be warranted to explore this potential link, indicating that it may provide new insights into the understanding of gallbladder disease pathology.",1,"To determine if there is a plausible explanation for the association between 'Concentration of Very Large VLDL Particles' and diseases such as cholelithiasis, gallstones, gallbladder disease, cholecystitis, or cholangitis, we need to consider the metabolic pathways involved. Very Low-Density Lipoproteins (VLDL) are primarily involved in the transport of triglycerides from the liver to peripheral tissues. An increase in VLDL concentration can lead to higher levels of triglycerides in the bloodstream, which may contribute to the formation of gallstones, as high triglyceride levels can influence bile composition and lead to supersaturation of cholesterol in bile. This supersaturation is a known risk factor for gallstone formation. Additionally, conditions that elevate VLDL levels, such as metabolic syndrome, are also associated with gallbladder diseases. Therefore, the positive correlation of 0.015, while weak, suggests that there may be a mechanism linking elevated VLDL levels to gallbladder-related diseases, making the association plausible. Thus, it makes sense to conclude that there is a plausible explanation for this relationship.",TRUE,4,"The feature 'Concentration of Very Large VLDL Particles' in relation to gallbladder diseases is interesting for several reasons. Firstly, the novelty aspect is quite significant. The specific correlation between very large VLDL particles and gallbladder diseases such as cholelithiasis or cholecystitis is not well-documented in existing literature, which primarily focuses on cardiovascular implications of VLDL. This suggests a novel area of research that could uncover new insights into gallbladder disease mechanisms. Secondly, the plausibility of this association is supported by known biological mechanisms. VLDL particles are involved in triglyceride transport, and elevated triglycerides can alter bile composition, potentially leading to cholesterol supersaturation and gallstone formation. This provides a logical pathway that could explain the observed correlation. Lastly, the potential utility of this feature is notable. If further research confirms this association, it could lead to new diagnostic markers or therapeutic targets for gallbladder diseases, enhancing clinical practice. Given these points, the feature is both novel and plausible, making it an interesting subject for further investigation.",0.015,0,0.001,0.001,1.88,0.69 <= Concentration of Very Large VLDL Particles < 0.71,FALSE,"The association between the feature 'Concentration of Very Large VLDL Particles' and the target disease 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is related to the formation of cholesterol gallstones. The formation of cholesterol gallstones is associated with an excess of cholesterol in the bile, which can be caused by an increased concentration of very large VLDL particles. This is because VLDL particles are a source of cholesterol in the body, and an excess of these particles can lead to an increase in cholesterol in the bile, which can then precipitate out as gallstones. This is a known risk factor for the development of gallstones and gallbladder disease.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,Elevated VLDL (triglyceride-rich) can influence bile cholesterol; moderately useful metabolic marker for risk assessment.,TRUE,3,,,,,,,,,,,,,,,,,,,,,positive
12,Apolipoprotein B to Apolipoprotein A1 ratio,1,"The association between the Apolipoprotein B to Apolipoprotein A1 ratio and gallbladder diseases such as cholelithiasis or gallstones is not extensively documented in the provided documents. While there are mentions of apolipoproteins in relation to various diseases, including gallstones, the specific correlation of the ApoB/A1 ratio with gallbladder disease is not highlighted as a well-established or novel finding. Document [6] discusses serum lipid and apolipoprotein levels in relation to gallstones but does not specifically mention the ApoB/A1 ratio. Therefore, the relationship appears to be underexplored and does not contradict established understanding but rather suggests a potential area for further research. Thus, it can be considered novel in the context of the current literature.",1,"The apolipoprotein B to apolipoprotein A1 ratio (ApoB/A1 ratio) is a known marker for cardiovascular risk, reflecting the balance between pro-inflammatory and anti-inflammatory lipoproteins. A higher ratio indicates a higher level of apolipoprotein B (associated with low-density lipoprotein, LDL) relative to apolipoprotein A1 (associated with high-density lipoprotein, HDL). In the context of gallbladder disease, including cholelithiasis (gallstones), the lipid metabolism is crucial. Gallstones are often formed from cholesterol, and dyslipidemia (abnormal lipid levels) can contribute to their formation. The positive correlation of 0.015 suggests a weak association, but it is still relevant. Increased levels of apolipoprotein B may indicate higher cholesterol levels, which could lead to gallstone formation. Therefore, there is a plausible mechanism linking the ApoB/A1 ratio to gallbladder disease through cholesterol metabolism and the formation of gallstones. Thus, it makes sense to consider this association as plausible.",TRUE,4,"1. **Novelty:** The association between the Apolipoprotein B to Apolipoprotein A1 ratio and gallbladder diseases is not extensively documented in existing literature. While apolipoproteins are discussed in relation to various diseases, the specific correlation of the ApoB/A1 ratio with gallbladder disease is not well-established. This suggests a novel area for research, as it is not a commonly explored or understood association.

2. **Plausibility:** The ApoB/A1 ratio is a marker for cardiovascular risk, reflecting the balance between pro-inflammatory and anti-inflammatory lipoproteins. Gallstones are often formed from cholesterol, and dyslipidemia can contribute to their formation. The mechanism linking the ApoB/A1 ratio to gallbladder disease through cholesterol metabolism is plausible, as increased levels of apolipoprotein B may indicate higher cholesterol levels, which could lead to gallstone formation.

3. **Usefulness:** If further research confirms the association, this feature could have practical applications in predicting gallbladder disease risk, potentially informing clinical interventions or screenings. However, the current correlation is weak, suggesting limited immediate utility.

Overall, the feature is interesting due to its novelty and plausible biological mechanism, despite the weak correlation strength.",0.015,0,0.001,0.001,1.27,Apolipoprotein B to Apolipoprotein A1 ratio >= 3.10,FALSE,"The association between the feature 'Apolipoprotein B to Apolipoprotein A1 ratio' and 'Cholelithiasis OR Gallstone OR Gallbladder disease OR cholecystitis OR Cholangitis' is not directly mentioned in the provided documents. However, it can be inferred that Apolipoprotein B is a risk factor for cardiovascular disease and atherosclerosis, which is related to the development of gallstones. Apolipoprotein A1 is an antinucleating factor for cholesterol monohydrate crystals, which are a key component of cholesterol stones. Therefore, a higher Apolipoprotein B to Apolipoprotein A1 ratio may indicate an increased risk of developing gallstones or gallbladder disease.",(Cholelithiasis) OR (Gallstone) OR (Gallbladder disease) OR (cholecystitis) OR (Cholangitis),1,"Reflects atherogenic vs. protective lipoproteins; relevant to cholesterol stone risk, moderately useful in lipid-related gallbladder assessment.",TRUE,3,,,,,,,,,,,,,,,,,,,,,positive
